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Work on rodents demonstrated that steep up-regulation of KCC2, a neuron-specific Cl- extruder of 
cation-chloride cotransporter (CCC) family, commences in supraspinal structures at around birth, 
leading to establishment of hyperpolarizing GABAergic responses.  
We describe spatiotemporal expression profiles of the entire CCC family in human brain. KCC2 
mRNA was observed already at 10th postconceptional week (PCW) in amygdala, cerebellum and 
thalamus. KCC2-immunoreactive (KCC2-ir) neurons were abundant in subplate at 18 PCW. By 25 
PCW numerous subplate and cortical plate neurons became KCC2-ir. The mRNA expression profiles 
of α and β isoforms of Na-K ATPase, which fuels cation-chloride cotransport, as well of tropomyosin 
receptor kinase B (TrkB), which promotes developmental up-regulation of KCC2, were consistent 
with data from studies on rodents about their interactions with KCC2. 
Thus, in human brain, expression of KCC2 and its functionally-associated proteins begins in 
early fetal period. Our work facilitates translation of results on CCC functions from animal studies to 
human and refutes the view that poor efficacy of anticonvulsants in the term human neonate is 
attributable to lack of KCC2. We propose that perinatally low threshold for activation of Ca2+-
dependent protease calpain renders neonates susceptible to down-regulation of KCC2 by traumatic 
events, such as perinatal hypoxia-ischemia.  
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The mechanisms regulating the intracellular Cl- concentration ([Cl-]i) are of fundamental importance in 
major changes that take place in neuronal signaling during brain development, such as the canonical 
shift of GABAergic transmission from depolarizing to hyperpolarizing which is caused by up-
regulation of the neuron-specific K-Cl cotransporter KCC2 (Rivera et al. 1999; Kaila et al. 2014a). In 
addition to this, cation-chloride cotransporters (CCCs), most notably KCC2, play important roles in 
the generation, maintenance and plasticity of neuronal connections (Payne et al. 2003; Ben-Ari et al. 
2007; Blaesse et al. 2009; Kaila et al. 2014a). Alterations in the function of CCCs have been 
implicated in several neurological disorders (Blaesse et al. 2009; Kahle et al. 2013; Kaila et al. 2014a). 
While a considerable amount of data on CCCs have been obtained in work on laboratory rodents (cf. 
Ben-Ari et al. 2007; Kaila et al. 2014a), there is little information on their developmental expression 
patterns in the human brain. Novel information of the kind described above has general implications 
for human developmental neurobiology, and specific implications for the use of neuronal CCCs as 
drug targets in the neonate (Puskarjov et al. 2014a). 
The solute carrier 12 (SLC12) gene family encompassing the CCCs is composed of nine 
members (SLC12A1–9), seven of which (SLC12A1–7) encode for molecules that act as Cl- 
transporters. Based on their sequence similarity and transport modes, the CCCs are divided into two 
major functional branches: the Na+-dependent Na-(K)-Cl cotransporters (NKCC1, NKCC2 and NCC, 
respectively encoded by SLC12A2, SLC12A1 and SLC12A3) and the K-Cl cotransporters (KCC1–4, 
encoded by SLC12A4-7). The free energy for ion transport by CCCs is derived from the 
electrochemical Na+ and K+ transmembrane gradients maintained by the Na-K ATPase, which is 
intimately co-expressed and co-regulated with the CCCs (Ikeda et al. 2004; Kaila et al. 2014a; 2014b; 
Khirug et al. 2010; Fujii et al. 2010). In most CNS neurons, the ubiquitously expressed NKCC1 and 
the neuron-specific KCC2 are responsible for the generation of ionic driving forces of GABAA and 
glycine receptor (GABAAR and GlyR)-mediated responses (Kaila et al. 2014a). Prior to the robust 
developmental up-regulation of KCC2, which renders GABAAR currents hyperpolarizing, a high 
































































intracellular Cl- concentration ([Cl-]i) and depolarizing responses to GABA are maintained by NKCC1 
in immature cortical principal neurons (Ben-Ari et al. 2007; Kaila et al. 2014a).  
The available expression data on the SLC12 gene family in the human brain are scarce (cf. 
Gagnon and Fulvio 2013) and no spatiotemporal CNS expression profile of the entire SLC12 family 
has been published. In particular, the available human data are inconsistent with regard to KCC2 
(Dzhala et al. 2005; Vanhatalo et al. 2005; Aronica et al. 2007; Bayatti et al. 2008; Jansen et al. 2010; 
Robinson et al. 2010; Hyde et al. 2011). Some studies report KCC2 protein expression not only in the 
subplate but also in the cortex in the early fetal period (Bayatti et al. 2008; Robinson et al. 2010), 
while others suggest that it occurs in the forebrain after term birth (Dzhala et al. 2005; Aronica et al. 
2007; Jansen et al. 2010).  
The neuron-type and region-dependent expression patterns of KCC2 during brain development 
have been extensively studied in animal models (for review, see Uvarov et al. 2013; Kaila et al. 
2014a). In mammals, KCC2 is abundantly expressed in mature central neurons, with very little or no 
expression in peripheral neurons, neuronal progenitors and non-neuronal cell types, including glia 
(Blaesse et al. 2009; Gagnon and Di Fulvio 2013; Kaila et al. 2014a; Uvarov et al. 2013). At the 
subcellular level, KCC2 is expressed in neuronal cell bodies, dendrites, and dendritic spines, but it is 
excluded from the axon initial segment and the axon proper (Gulyas et al. 2001; Hübner et al. 2001b; 
Szabadics et al. 2006; Baldi et al. 2010; Fiumelli et al. 2013). Up-regulation of KCC2 expression takes 
place strictly in parallel with neuronal differentiation, as reflected in the gradual increase in the caudal-
to-rostral direction of the CNS (Li et al. 2002; Stein et al. 2004; Wang et al. 2002). In the caudal parts 
of the rodent CNS, such as the spinal cord and much of the brainstem, perinatal KCC2 expression 
patterns are comparable to those observed in older animals (Stein et al. 2004; Blaesse et al. 2006; 
Balakrishnan et al. 2003; Uvarov et al. 2009). In the more rostral regions, such as the hippocampus 
and the neocortex, robust up-regulation of KCC2 mRNA commences by the time of birth 
(Balakrishnan et al. 2003; Rivera et al. 1999; Wang et al. 2002; Li et al. 2002; Stein et al. 2004), 
reaching a plateau around the third postnatal week (Wang et al. 2002; Rivera et al. 1999). In keeping 
with the general differences in the milestones of CNS development (Erecinska et al. 2004), the timing 
































































of KCC2 up-regulation with regard to birth is not only brain region- but also species-specific. For 
instance, in the cortex of neonatal rats and mice, GABA is depolarizing while in the guinea pig – a 
species with precocious neonates – cortical up-regulation of KCC2 takes place before birth and 
neonatal guinea pig cortical neurons show hyperpolarizing GABAergic responses (Rivera et al. 1999). 
Regardless of the relatively low levels of cortical KCC2 in newborn mice and rats, robust alterations 
in synaptic and network functions in the hippocampal CA3 region have been reported in KCC2 
knockout mice at embryonic day 18.5 (Khalilov et al. 2011). This strongly indicates that expression of 
KCC2 is critical for the development and function of cortical neurons in this species already before 
birth (see also Horn et al. 2010). 
The steep increase in KCC2 expression in the rodent cortex during the first postnatal month 
(Kovacs et al. 2014; Stein et al. 2004; Sun et al. 2013; Takayama and Inoue 2010) is associated with 
both the maturation of GABAergic hyperpolarizing inhibition (Rivera et al. 1999) and with intense 
glutamatergic synaptogenesis and spine formation (De Felipe et al. 1997; Juraska 1982; Fiumelli et al. 
2013). KCC2 is not only a key molecule for inhibitory signaling, but its expression is also tightly 
associated with the morphological development and function of cortical dendritic spines in a manner 
that is independent of its function as an ion transporter (Li et al. 2007; Gauvain et al. 2011; Chamma et 
al. 2012; Fiumelli et al. 2013; Puskarjov et al. 2014b; Blaesse and Schmidt 2014; Kaila et al. 2014a). 
In vivo overexpression of KCC2 or its transport-inactive construct is sufficient for de novo 
spinogenesis and formation of functional glutamatergic synapses (Fiumelli et al. 2013; Puskarjov et al. 
2014b). Indeed, in a variety of non-human species, the developmental expression of KCC2 has been 
shown to intimately parallel that of synaptophysin (Ludwig et al. 2003; Zhang et al. 2006; Takayama 
and Inoue 2006; Bayatti et al. 2008), a molecule routinely used as a proxy for density of glutamatergic 
synapses (Calhoun et al. 1996; Eastwood et al. 2006). KCC2 is thus likely to act as a coordinating 
factor in the parallel development and plasticity of synaptic inhibition and excitation (Li et al. 2007; 
Chamma et al. 2012; Blaesse and Schmidt 2014; Kaila et al. 2014a; Puskarjov et al. 2014b). Recently, 
a KCC2 point variant found in patients with febrile seizures (Puskarjov et al. 2014b) and idiopathic 
































































generalized epilepsy (Kahle et al. 2014) was shown to lead to deficits in both neuronal Cl- extrusion 
capacity and the formation of cortical dendritic spines (Puskarjov et al. 2014b).  
Multiple factors have been implicated in controlling the transcriptional up-regulation of 
mammalian KCC2 (Uvarov et al. 2005; 2006; Markkanen et al. 2008; Yeo et al. 2009; Ludwig et al. 
2011a; 2011b). Most notably, signaling mediated by TrkB (Aguado et al. 2003; Carmona et al. 2006; 
Ludwig et al. 2011b). While the major endogenous ligand of TrkB receptors, brain-derived 
neurotrophic factor (BDNF), is not necessary for the developmental up-regulation of KCC2 
(Puskarjov et al. 2015), signaling mediated by these receptors appears nevertheless to be a major 
driver of Slc12a5 transcription in immature rodents (cf. Aguado et al. 2003; Ludwig et al. 2011b). 
Importantly, levels of mRNA encoding KCC2 are decreased in mice lacking TrkB expression 
(Carmona et al. 2006). Previous studies on the expression of TrkB in the human brain have been 
performed mostly on postnatal brain tissue (Romanczyk et al. 2002; Webster et al. 2006; Luberg et al. 
2010). Interestingly, near adult-level expression of full-length TrkB protein has been reported in the 
prefrontal cortex of human neonates (Luberg et al. 2010), however, there is paucity in the data 
regarding the temporal profile of TrkB expression in the fetal human brain. 
Down-regulation of KCC2 has been demonstrated to take place following various neuronal 
insults via activation of Ca2+-dependent mechanisms, typically downstream of TrkB (Kaila et al. 
2014b). We and others have shown that activity-dependent down-regulation of transport-active KCC2 
at the post-translational level is a direct consequence of cleavage of the C-terminal domain of KCC2 
by either of the two CNS calpains (Puskarjov et al. 2012, 2015; Zhou et al. 2012; Chamma et al. 2013; 
Jantzie et al. 2014; Kaila et al. 2014a). Hypoxic-ischemic encephalopathy is among the major 
contributors to long term neurological sequelae in term and pre-term infants, with a close correlation 
between increased cellular Ca2+ uptake and subsequent hypoxic-ischemic neuronal damage within 
ischemic brain regions (Volpe 2008). Calpains are Ca2+-activated non-promiscuous proteases 
important for many intracellular processes, such as turnover of cytoskeletal proteins and regulatory 
cleavage of synaptic proteins, and have been widely implicated in synaptic plasticity as well as 
neurodegeneration (Goll et al. 2003; Liu et al. 2008; Baudry et al. 2013). In the CNS, calpain 1 and 
































































calpain 2 are the main calpain isoforms and are respectively activated by intracellular Ca2+ 
concentrations in the micro- and millimolar range (Goll et al. 2003). Activation of calpains is 
restricted by calpastatin, an endogenous calpain-specific inhibitor (Blomgren et al. 1999; Goll et al. 
2003; Yang et al. 2013). Notably, calpain overexpression and/or overactivation has been demonstrated 
to take place in the context of hypoxia-ischemia (Ostwald et al. 1993; Blomgren et al. 1999; 
Rosenkranz et al. 2012), seizures (Sierra-Paredes et al. 1999; Fujikawa 2005; Puskarjov et al. 2015), 
and epilepsy (Feng et al. 2011; Das et al. 2012; Kaila et al. 2014b). Interestingly, work on non-human 
animals suggests that the perinatal period is characterized by a high calpain/calpastatin ratio (Li et al. 
2009; Blomgren et al. 1989; Blomgren and Karlsson 1989) and, thus, a low threshold for calpain 
activation (cf. Simonson et al. 1985; Blomgren and Karlsson 1989; Blomgren et al. 1989; Lu et al. 
2000). While down-regulation of KCC2 protein has been reported to take place in preterm infants with 
white matter lesions (Robinson et al. 2010), it is not known whether this may reflect a heightened 
susceptibility of KCC2 to calpain cleavage during the perinatal period. 
Here, we performed a two-tier analysis of CCC expression in the human brain across 
development. First, we used microarray data to analyze the spatiotemporal patterns of SLC12A1-9 
mRNA expression in the human brain, and we report for the first time the spatiotemporal expression 
profile of the entire SLC12 gene family in the human cerebrum, thalamus and cerebellum. Second, we 
used KCC2 immunohistochemistry to validate the microarray data on KCC2 expression. Importantly, 
we found that both SLC12A5 mRNA and KCC2 protein are robustly up-regulated in the human brain 
by term birth. Moreover, this is associated with functionally compatible developmental expression 
patterns of the Na-K ATPase, TrkB, and of synaptic markers. Our work also suggests that the poor 
efficacy of GABAAR enhancing anticonvulsant drugs in human neonates is not attributable to lack of 
cortical KCC2 expression, but is more likely related to the high susceptibility of the perinatal human 
cortex to KCC2 down-regulation by the calpain system.  
 
 
































































Materials and Methods 
Microarray data analysis 
For the analysis of mRNA expression we used our previously published microarray database (Kang et 
al. 2011) available from the Gene Expression Omnibus (GEO accession GSE 25219, Human Exon 1.0 
ST Array). The dataset is composed of 1340 brain tissue samples encompassing the entire human 
lifespan (age range 5 PCW–82 years) and covering 16 brain regions (for details see Suppl. Table 1, 
and Kang et al. 2011). Partek Genomic Suite 6.6 (Partek Inc.) was used to normalize data and 
summarize probe set and transcript clusters. Affymetrix CEL files were imported into Partek Genomic 
Suite using default Partek settings. Analysis was done on the probe sets designated as ‘core’ and 
‘extended’ using Partek Genomic Suite 6.6 and R Statistical Software Package (http://www.r-
project.org). The analyzed probe sets covered the entire span of the gene. Therefore, in the subsequent 
analysis all known mRNA isoforms were included and data presented is the average expression of all 
isoforms. The median of all probesets within one gene was used as the estimate of gene expression. 
The data is presented as log2-transformed value of the signal intensity and a gene was considered as 
expressed when the log2-transformed expression value in the analyzed sample was ≥5.5 (cf. Kang et 
al. 2011).  
 
Immunohistochemistry 
To analyze the developmental expression patterns of KCC2 in the human brain at protein level, we 
took advantage of the extensive Zagreb Collection of human brains and indirect 
immunohistochemistry (Kostovic et al. 1991; Judas et al. 2011). Nissl stainings were performed on 
adjacent histological sections for delineation of developmental layers and cytoarchitectonic boundaries 
and cellular compartments. In total 17 human postmortem brains were analyzed, including 13 fetal 
brains (age range: 16–40 PCW), 2 infant brains (aged 3 and 13 months), one child brain (aged 6.5 
years) and one adult brain (aged 51 years). Brains were collected at the pathology department of the 
































































University of Zagreb School of Medicine. Fetal brain specimens were obtained either from medically-
indicated or spontaneous abortions or subsequent to the death of prematurely born neonates. Fetal ages 
were determined on the basis of crown-rump lengths and pregnancy records, and expressed as PCW. 
All postnatal brain specimens were collected during autopsies according to the protocol approved by 
the Institutional Review Board with the parental or next of kin consent. The brains analyzed in this 
study did not exhibit microscopic or macroscopic signs of pathological changes.  
Whole brains (postmortem delay 6–24 hrs, for details see Suppl. Table 2) were immersion-fixed 
using 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). Subsequently, tissue blocks were 
either frozen or embedded in paraffin and cut in coronal plane at a thickness of 20 µm (paraffin-
embedded tissue) or 100 µm (frozen tissue). Immunohistochemistry was performed according to 
standard protocols (Hsu et al. 1981). Following dewaxing and rehydration in PBS, antigen retrieval of 
deparaffinized sections was achieved by microwave heating on 95°C/30 min in citrate buffer saline 
(pH 6). Thereafter, all sections were pre-treated in 0.3% H202 in a 3:1 mixture of methanol and 
distilled water for quenching of endogenous peroxidase and washed for 10 min in PBS. To prevent 
non-specific background staining sections were immersed in blocking solution (3% bovine serum 
albumin and 0.5% Triton X-100 in PBS; all from Sigma) for 2 hrs at room temperature (RT) and then 
incubated overnight at 4°C with a polyclonal rabbit-anti-KCC2 C-terminal primary antibody (1:2000) 
(Ludwig et al. 2003). Following a 1 h wash in PBS, a biotinylated anti-rabbit secondary antibody 
(Vectastain ABC kit) was applied (1:200 in blocking solution) for 1h at RT. The sections were then 
washed for 1 h and immersed in streptavidin/peroxidase complex (1:500 in PBS) (Vectastain ABC kit) 
for 1h at RT. The peroxidase activity was visualized using Ni-3,3-diaminobenzidine (Sigma). Sections 
were then dehydrated in graded series of alcohol, cleared in xylene and cover-slipped using 
Histomount (National Diagnostics). Negative controls were included in all experiments: by either 
replacing the primary antibody with blocking solution or preimmune goat or horse serum or by 
omitting secondary antibody or replacing it with anti-mouse secondary antibody. No immunolabeling 
was detected in these control sections. Qualitative analysis of the sections was performed using an 
Olympus Provis AX70 upright microscope (Olympus), and sections were digitized using a 
































































NanoZoomer 2.0-RS digital slide scanner (Hamamatsu Photonics) at 400x magnification. Selected 
images were exported from virtual slides using NDP.view2 software (Hamamatsu Photonics) and 
processed using Adobe Photoshop CS5 (Adobe Systems). 


































































Spatio-temporal expression patterns of SLC12A1-9 mRNA in the human brain 
Microarray mRNA expression data of the nine known members of the SLC12A family was analyzed in 
16 human brain regions at 13 different developmental periods (Fig. 1, Suppl. Fig. 1, Suppl. Table 1). 
Five members (SLC12A1 [encoding for NKCC2], SLC12A3 [NCC], SLC12A7 [KCC4], SLC12A8 
[CCC9], and SLC12A9 [CIP1]) of the SLC12A family were not detected in any of the brain regions 
analyzed at any developmental period (Suppl. Fig. 1; Suppl. Tables 3–7). Two (SLC12A2 [NKCC1] 
and SLC12A6 [KCC3]) were observed in all regions at all periods (Fig. 1; Suppl. Tables 8 and 9) and 
displayed an opposite pattern of mRNA expression. SLC12A2 exhibited lower levels during the 
prenatal period (10 PCW–birth) with an increase in expression during the postnatal period (birth–90 
years). SLC12A6 exhibited higher levels during the prenatal period with a decrease in expression 
during the postnatal period. The remaining two CCCs genes, SLC12A4 [KCC1] and SLC12A5 
[KCC2], displayed a restricted spatio-temporal pattern of transcript expression. SLC12A4 was limited 
to the cerebellar cortex, hippocampus, striatum and the mediodorsal nucleus of the thalamus (Fig. 1, 
Suppl. Table 10). SLC12A4 was first observed in the cerebellar cortex between 10-13 PCW, followed 
by expression in other regions between 24 PCW and birth (Fig. 1). In contrast, SLC12A5 was detected 
in all regions with a prominent developmental up-regulation across the brain regions examined (Fig. 1, 
Suppl. Table 11). The amygdala, cerebellar cortex and the mediodorsal nucleus of the thalamus were 
the first regions where SLC12A5 mRNA was observed (at 10–13 PCW), followed by hippocampus, 
striatum and the neocortex (at 16–19 PCW; Fig. 1). By 19–24 PCW SLC12A5 mRNA was present in 
the majority of neocortical regions, with one region (primary motor cortex) expressing KCC2 at an 
earlier period (16–19 PCW) and two regions (dorsolateral frontal cortex, and primary visual cortex) 
somewhat later (24 PCW–birth). A significant level of mRNA encoding KCC2 was present during the 
last trimester of pregnancy in all analyzed neocortical regions and an adult-like level was reached 
between birth and the sixth postnatal month (Fig. 1). 

































































Expression patterns of KCC2 protein in the developing human brain 
Following the analysis of microarray mRNA expression data, we studied the developmental 
expression patterns of KCC2 protein in the human brain. At 16 PCW, no KCC2-immunoreactive 
(KCC2-ir) neurons were observed either in the cortical plate or the subplate (Fig. 2A, F). We first 
identified KCC2-ir neurons in the subplate at 18 PCW, with only few scattered KCC2-ir neurons in 
the cortical plate. These data are in close agreement with a previous immunohistochemical study 
reporting that in the developing neocortex, KCC2 is first expressed in the inner subplate by 16 PCW 
(Bayatti et al. 2008). From 25 PCW onwards, KCC2-ir neurons were readily observed in both the 
cortical plate and the subplate (Fig. 2B–D, G–I; Suppl. Fig. 2). In the adult brain, KCC2-ir neurons 
were present in all neocortical layers as well as in the subcortical (gyral) white matter (Fig. 2E, J). In 
the cingulate cortex at 20 PCW, KCC2-ir neurons were present in the subplate but not in the cortical 
plate, where they appeared at 25 PCW (Suppl. Fig. 3A). At that age, KCC2-ir was present in somata 
and proximal dendrites of cortical plate neurons (Suppl. Fig. 3A), as well as in subplate neurons 
(Suppl. Fig. 3E); and this pattern of expression remained similar until birth (Suppl. Fig. 3B, F). By the 
time of birth, strong KCC2-ir was present in somata and proximal dendrites of neurons of all cortical 
layers (Suppl. Fig. 3C, D) as well as in subplate neurons (Suppl. Fig. 3G) which transform, after first 
year of life, into interstitial neurons of the subcortical white matter (Suppl. Fig. 3H).  
In the hippocampus and the entorhinal cortex, KCC2-ir neurons were present already at 25 
PCW which, for these regions, was the earliest age analyzed. KCC2-ir neurons with clearly stained 
somata and proximal dendrites could be observed in the hippocampus and entorhinal cortex from 25 
PCW onwards (Fig. 3A–H). Strong KCC2-ir of somata and proximal dendrites was also observed in 
thalamic neurons starting at 22 PCW (Suppl. Fig. 4). Strong KCC2 staining was noted in globus 
pallidus neurons already at 22 PCW (Suppl. Fig. 5A), and this was the region with the highest level of 
KCC2-ir throughout development (Suppl. Fig. 5B, C). This raises the interesting possibility that the 
high immunoreactivity is attributable to KCC2 located in the spines of medium spiny interneurons (cf. 
































































Gulyas et al. 2001). Qualitatively similar, but less pronounced KCC2-ir staining of somata and 
proximal dendrites was also observed in neurons of claustrum (Suppl. Fig. 5D), nucleus caudatus 
(Suppl. Fig. 5E) and putamen (Suppl. Fig. 5F).  
 
Developmental expression of TrkB mRNA in the human brain 
With regard to the likely role of TrkB in the up-regulation of KCC2 in the human fetal brain, we 
analyzed the expression patterns of NTRK2 transcripts encoding for TrkB in the same brain regions as 
for SLC12A5. Strikingly, prenatal up-regulation of NTRK2, reaching an adult-like level around birth, 
was observed in all brain regions investigated (Fig. 4, Suppl. Table 12). A temporal expression profile 
similar to that of SLC12A5 was particularly evident in the neocortex and the hippocampus (Fig. 4).  
 
Spatio-temporal expression patterns of Na-K ATPase α and β subunit mRNA in the human brain 
The expression level of the Na-K ATPase subunits may pose as a limiting factor for the Cl--transport 
function of CCCs (see Introduction). Therefore, we analyzed the spatiotemporal mRNA expression 
data of the Na-K ATPase α1-4 (ATP1A1-4) and β1-4 (ATP1B1-4) in the same regions and 
developmental stages as for the genes encoding for the SLC12 family members. Two of the subunit 
genes (ATP1A4 and ATP1B4) were not expressed in any of the brain regions analyzed at any 
developmental period (Figs.5 and 6; Suppl. Tables 16 and 20). Expression of the α4 subunit is largely 
restricted to the testis in humans and rats (Shamraj and Lingrel 1994). In contrast, ATP1A1-3 (Fig. 5; 
Suppl. Tables 13-15) and ATP1B1-3 (Fig. 6; Suppl. Tables 17-19) mRNA were observed in all 
analyzed regions at all periods. Expression of ATP1A2 became significant in all analyzed regions by 
16-19 PCW (Fig. 5; Suppl. Table 14) and, together with ATP1B1-2 (Fig. 6; Suppl. Tables 17-18), 
underwent robust developmental up-regulation, similar to that of SLC12A5 (Fig 1; Suppl. Table 11), 
reaching adult-like expression levels in all studied brain regions around birth. ATP1A3 mRNA was at 
low but significant levels at all prenatal periods in all brain regions, except in the striatum (non-
































































significant at 24 PCW–birth), with postnatal decrease in all analyzed brain regions except mediodorsal 
nucleus of thalamus (Fig. 5; Suppl. Table 15). The above data suggest that the expression of neither α 
or β subunits of the Na-K ATPase is likely to be a limiting factor for the functionality of secondary-
active Cl- transporters in the developing human brain.  
 
Expression of synaptophysin and PSD-95 mRNA parallel up-regulation of KCC2 in the human 
brain 
While a previous immunohistochemical study demonstrated expression of both KCC2 and 
synaptophysin as early as 16 PCW in the fetal human neocortex (Bayatti et al. 2008), the 
developmental relationship between synaptophysin and KCC2, observed in experimental animals, has 
not been investigated in the human brain. To shed light on this we analyzed the microarray mRNA 
expression data of SYP in the same brain regions and developmental periods as above for SLC12A5. 
SYP was significantly expressed in all of the 16 brain regions studied starting from 10 PCW and 
underwent progressive up-regulation, temporally paralleling that of SLC12A5, and reaching adult-like 
levels around birth in all investigated brain regions (Fig. 7; Suppl. Table 21). As synaptophysin is 
expressed presynaptically, we also investigated the spatiotemporal mRNA expression profiles of the 
major postsynaptic density protein PSD-95 (encoded in humans by DLG4). In line with the data 
obtained for SYP, DLG4 exhibited high levels of expression in all brain regions analyzed with 
significant prenatal up-regulation by the time of birth in all regions investigated (Fig 7: Suppl. Table 
22). One exception here was the cerebellar cortex, where a constantly high expression level of DLG4 
was observed. 
Together these data support the hypothesis that, akin to observations made in animal models 
(Ludwig et al. 2003; Takayama and Inoue 2006; Zhang et al. 2006; Fiumelli et al. 2013; Kaila et al. 
2014a), up-regulation of KCC2 gene expression spatiotemporally coincides with an intense period of 
synaptogenesis also in humans. Indeed, the most intense phase of synaptogenesis in humans, or the 
































































brain growth spurt, is observed between the third trimester of pregnancy and the first few years of life 
(Huttenlocher et al. 1982; Huttenlocher and Dabholkar 1997; Petanjek et al. 2011).  
 
Inverse relationship of calpain and calpastatin mRNA levels in the perinatal human brain 
Studies performed in rodents and rabbits have demonstrated that a salient feature of the immature 
brain is a higher proteolytic potential of the calpain system when compared to later stages in life 
(Simonson et al. 1985; Blomgren and Karlsson 1989; Blomgren et al. 1989; Lu et al. 2000). This 
effect is likely to be attributable to the fact that the highest calpain to calpastatin ratio is observed 
before and around birth in these experimental animals (Li et al. 2009; Blomgren et al. 1989; Blomgren 
and Karlsson 1989). To investigate whether this is true also in humans, we analyzed in the same brain 
regions as in those above for SLC12A5 the spatiotemporal expression patterns of mRNA encoding for 
the large subunits of calpain 1 and 2 (CAPN1 and CAPN2, respectively), the small regulatory subunit 
(CAPNS1) common to both calpains, and mRNA encoding for the endogenous calpain inhibitor 
calpastatin (CAST). Strikingly, in the majority of brain regions analyzed, most notably in neocortical 
areas, we observed a large pre to perinatal trough in the developmental expression profile of CAST that 
was paralleled by a developmental peak in the expression of CAPN1 (Fig. 8; Suppl. Table 23). In the 
neocortex, expression of both CAPN1 and CAPN2 significantly exceeded that of CAST throughout 
pregnancy and until the second half of the first year of life, with the highest calpain to calpastatin 
mRNA ratio during the last trimester (Fig. 8; Suppl. Tables 23-25). The expression of CAPNS1 
encoding for the small regulatory unit of calpain 1 and 2 was high throughout life (Fig. 8; Suppl. Table 
26), and its expression is thus unlikely to act as a limiting factor for calpain activity at any given 
developmental period.  
The above human data are in line with observations made in experimental animals that the 
threshold for activation of CNS calpains is likely to be lowest during late pregnancy and early 
postnatal life. More specifically, it indicates that the immature brain is particularly susceptible to 
calpain-mediated down-regulation of KCC2 under conditions of neuronal damage. This finding 
































































provides a novel point of vantage into the poor efficacy of GABA-enhancing anticonvulsant in 
neonates with hypoxic-ischemic encephalopathy.  
 
Discussion 
This is the first study on the spatiotemporal expression of the entire SLC12 family across human CNS 
development (see Introduction). In particular, this kind of data are needed on KCC2 which is of unique 
importance because of its critical roles in the development of both inhibitory and excitatory signaling, 
and as a potential novel drug target (Gagnon et al. 2013; Löscher et al. 2013b; Kaila et al. 2014a; 
Puskarjov et al. 2014a). The present data provide the mRNA expression profiles of SLC12A1-9 in 16 
brain regions (11 neocortical areas, hippocampus, amygdala, mediodorsal nucleus of thalamus, and 
cerebellar cortex) from 10 PCW to 82 years of age.  
Our microarray and immunohistochemical data indicate that prominent up-regulation of KCC2 
takes place in the human cortex already in utero, in contrast to the largely postnatal expression of 
KCC2 in mice and rats. These data corroborate previously published results linking prenatal up-
regulation of SLC12A5 mRNA with salient changes in the properties of human EEG (Vanhatalo et al. 
2005). The cortical EEG of neonatal rats and preterm infants is discontinuous and dominated by 
discrete network events (Khazipov and Luhmann 2006; Vanhatalo and Kaila 2006). In humans, such 
events disappear around the time of birth (Vanhatalo et al. 2005), whereas in rats they persist until the 
second postnatal week (Leinekugel et al. 2002). Thus, in both species, the abolishment of the discrete 
network events closely parallels the developmental increase in cortical KCC2 (Rivera et al. 1999; 
Vanhatalo et al. 2005). 
Notably, the expression profiles of genes encoding key molecules associated with functional 
expression of KCC2 (especially the Na-K ATPase) are consistent with the above conclusion. In line 
with the multifunctional role of human KCC2 in GABAergic signaling and spinogenesis (Kaila et al. 
2014a; Puskarjov et al. 2014b), the spatiotemporal expression profiles of SYP and DLG4 mRNA, 
































































respectively encoding for the synaptic markers synaptophysin and PSD-95, were highly similar to that 
of KCC2. 
 
Expression patterns of KCC2 in the fetal human brain 
The available data on KCC2 expression in the human brain are scarce and inconsistent (Dzhala et al. 
2005; Vanhatalo et al. 2005; Aronica et al. 2007; Bayatti et al. 2008; Jansen et al. 2010; Robinson et 
al. 2010; Hyde et al. 2011). The above studies focused either on a few time points or a single brain 
region and no systematic analysis of KCC2 protein or mRNA expression has been done. The first 
study to analyze expression in human brain tissue of the two CCCs critical for neuronal function, 
NKCC1 and KCC2, was done in the context of pathomechanisms that might underlie neonatal seizures 
in the perinatal human brain (Dzhala et al. 2005). The authors of this study suggested that the perinatal 
cerebral cortex of both rodents and humans is characterized by high NKCC1 and negligible levels of 
KCC2 protein, with gradual down-regulation of NKCC1 and up-regulation of KCC2 during the early 
postnatal period, the latter reaching adult-like levels after the first year of life (Dzhala et al. 2005; see 
also Jansen et al. 2010). Findings of that study are often cited in support for the view that the KCC2 
expression is low in brains of both preterm and term infants and that it justifies the treatment of 
neonatal seizures with NKCC1 acting agents, such as bumetanide (cf. Pressler et al. 2015; see also 
Puskarjov et al. 2014a).  
In contrast to the above study, we found that KCC2 expression in the human neocortex begins 
already during the midfetal period and reaches adult-like levels during the first six months of postnatal 
life. With respect to human neocortical anlage, we found that the KCC2 expression becomes well 
established between 18 and 25 PCW. This is in agreement with previous findings of KCC2 expression 
in the human subplate at 16 PCW (Bayatti et al. 2008) and in the cortical plate at 20 PCW (Robinson 
et al. 2010; Hyde et al. 2011). Our findings are also in agreement with the general differences in the 
milestones of neuronal development vs. time of birth, where neonate rats and mice are known to 
































































achieve a developmental state of the cortex which roughly corresponds to the start of the third 
trimester of gestation in the human fetus (cf. Clancy et al. 2001; Erecinska et al. 2004).  
The earlier expression of KCC2 in the subplate (18 PCW) than in the cortical plate (25 PCW) 
probably reflects the fact that subplate neurons are generated earlier and are more mature than neurons 
of the cortical plate (Hoerder-Suabedissen and Molnar 2015; Kanold and Luhmann 2010; Kostovic 
and Rakic 1990; Mrzljak et al. 1988; 1990; 1992), and that the subplate represents the major site of 
synaptogenesis in the human midfetal cerebral wall (Molliver et al. 1973). Between 15 and 24 PCW, 
the subplate serves as a waiting compartment for cortical afferent fibers which establish numerous 
temporary synapses with subplate neurons (Kostovic and Rakic 1990; Allendoerfer and Shatz 2003; 
Kostovic and Judas 2002; 2006; 2007). During the same period, future cortical plate neurons are still 
young postmitotic neurons which migrate through intermediate and subplate zone towards their final 
destination in the cortical plate, At 23 to 24 PCW, when most migratory neurons settle in the cortical 
plate, afferent fibers begin to relocate from the subplate into the cortical plate, which coincides with 
the onset of intense inside-out synaptogenesis within the cortical plate (Molliver et al. 1973; Kostovic 
and Rakic 1990). Notably, subplate ablation prevents the developmental up-regulation of KCC2 in 
cortical layer 4, the main target of thalamocortical axons and subplate neurons (Kanold and Shatz 
2006). Our present data suggests that KCC2 expression closely follows the pattern of neuronal 
differentiation, synaptogenesis and ingrowth of afferent fibers in the subplate and cortical plate during 
human brain development. Similar findings were reported in rodent cortical neurons where up-
regulation of KCC2 expression was demonstrated to take place in parallel with synaptogenesis 
(Gulyas et al. 2001; Ludwig et al. 2003; Zhang et al. 2006; Takayama and Inoue 2006; see also 
Fiumelli et al. 2013). Notably, in addition to its role as a K-Cl cotransporter, KCC2 is also critical for 
the formation and function of cortical dendritic spines in a manner that is independent of its ion 
transport function (Li et al. 2007; Chamma et al. 2012; Fiumelli et al. 2013; Blaesse and Schmidt 
2014; Kaila et al. 2014a; Puskarjov et al. 2014b). Thus, developmental up-regulation of KCC2 is 
likely to coordinate the development of the major inhibitory and excitatory synaptic signaling systems. 
































































 Presently, we observed that in addition to the robust up-regulation of KCC2 expression in 
utero, levels of mRNA encoding for KCC2 continue to increase postnatally during the first 6 months 
of life (Figs. 1,7-9). Similarly, work on the developing rodent cortex has demonstrated that after the 
time point when no further increase in Cl- extrusion capacity is observed in cortical principal neurons 
(Khirug et al. 2005) further up-regulation in the level of KCC2 protein takes place for up to two weeks 
thereafter (Sun et al. 2013; Uvarov et al. 2006). This suggests either a high safety factor for 
maintaining hyperpolarizing GABAergic responses in mature mammalian cortical principal neurons 
(see Diamond 2002; Puskarjov et al. 2014a); or that the further increase in KCC2 protein serves to 
facilitate the ion transport-independent functions of KCC2 in synaptogenesis. These two scenarios are 
mutually non-exclusive, and the latter is consistent with the notion that the peak synaptogenic period 
in humans takes place during infancy/early childhood (Huttenlocher and Dabholkar 1997; Petanjek et 
al. 2011) and in the rodent cortex after the ontogenetic shift to hyperpolarizing GABAAR signaling 
(De Felipe et al. 1997; Fiumelli et al. 2013; Juraska 1982). Notably, immature rodent hippocampal 
neurons have the capacity to optimize their use of the available KCC2 levels via increased membrane 
retention/expression of KCC2 in response to enhanced levels of network activity (Khirug et al. 2010; 
Bos et al. 2013), an effect that is dependent on BDNF-TrkB signaling (Khirug et al. 2010; Puskarjov et 
al. 2015).  
We also report that robust increase in Na-K ATPase α2 and β2 (and to lesser extent also α1 and 
β1) mRNA takes place in parallel with up-regulation of KCC2 in the human brain by term birth. 
Interestingly, recent work on rodent brain Na-K ATPase suggests that to form an active enzyme α1 
and α2 subunits assemble preferentially with β1 and β2 subunits, respectively (Tokhtaeva et al. 2012). 
The α1: β1 and α2:β2 mRNA level stoichiometry apparent in the present data supports the idea that 
this could be the case also for the human brain Na-K ATPase. Because the energy for Cl- transport by 
CCCs depends on the plasmalemmal K+ and Na+ gradients, it is interesting that the catalytic α subunits 
of the Na-K ATPase have been shown to be functionally co-regulated and even to structurally interact 
with CCCs, including KCC2 (Ikeda et al. 2004; Khirug et al. 2010) and KCC3 (Fujii et al. 2008; 2010; 
Fujita et al. 2012). Furthermore, analogous interactions between KCC4 and the H-K ATPase (Fujii et 
































































al. 2009) suggest that K-Cl cotransporters form ‘ion transport metabolons’ (Kaila et al. 2014b) with 
P-type ATPases. These metabolons may also include ATP-generating molecules, such as the brain 
type creatine kinase (Inoue et al. 2006; Salin-Cantegrel et al. 2008). Accordingly, transient 
enhancement in the efficacy of neuronal Cl- extrusion of immature pyramidal neurons in response to 
epileptiform activity (Khirug et al. 2010; Puskarjov et al. 2015) is paralleled by increased cell surface 
expression of both KCC2 and the α2 subunit of the Na-K ATPase (Khirug et al. 2010), and there is 
indication that this subunit directly interacts with transport-functional KCC2 and is necessary for 
neuronal Cl- extrusion (Ikeda et al. 2004). Interestingly, this kind of functional up-regulation of KCC2 
depends on the activation of TrkB (add here the refs Khirug et al. 2010; Puskarjov et al. 2015), the 
receptor of BDNF and NT4 (Park and Poo, 2013).  
Notably, we and others have shown that KCC2 is substrate of the Ca2+-dependent protease 
calpain (Puskarjov et al. 2012, 2015; Zhou et al. 2012; Chamma et al. 2013; Jantzie et al. 2014). This 
is important as the present study indicates that, as in other mammals (Li et al. 2009; Blomgren et al. 
1989; Blomgren and Karlsson 1989), the perinatal period in humans is characterized by a high 
calpain/calpastatin ratio. It appears that a high proteolytic potential of the calpain system is likely to be 
one of the hallmarks of the developing, and especially, perinatal mammalian brain. Indeed, during this 
developmental period calpains have been implicated in maintaining a high rate of synaptic turnover 
(Lu et al. 2000) in a neuronal activity-dependent Hebbian manner (cf. Lynch and Baudry 1984; Amini 
et al. 2013). From a clinical perspective, the present work indicates that, in parallel with an apparently 
smaller safety factor for KCC2 expression (see above), neonates, as compared to older infants and 
adults, may have a significantly lower threshold for calpain activation (cf. Simonson et al. 1985; 
Blomgren and Karlsson 1989; Blomgren et al. 1989; Lu et al. 2000) and thus higher susceptibility to 
calpain-mediated cleavage and functional down-regulation of KCC2 in response to hypoxic-ischemic 
insults and seizures (Robinson et al. 2010; Puskarjov et al. 2012, 2015; Chamma et al. 2013; Jantzie et 
al. 2014; see also Ostwald et al. 1993; Blomgren et al. 1999; Kawamura et al. 2005; Rosenkranz et al. 
2012; Andres et al. 2013). 
 
































































NKCC1 mRNA does not exhibit postnatal down-regulation in the human brain 
While some studies suggest that NKCC1 expression undergoes postnatal down-regulation (Plotkin et 
al. 1997; Hübner et al. 2001a; Shimizu-Okabe et al. 2002; Yamada et al. 2004; Dzhala et al. 2005; Liu 
and Wong-Riley 2012) other studies indicate a postnatal up-regulation of NKCC1 in the CNS during 
development in rodents (Clayton et al. 1998; Yan et al. 2001; Mikawa et al. 2002) and humans (Hyde 
et al. 2011; Morita et al. 2014). NKCC1 undergoes alternative mRNA splicing which results in two 
variants, NKCC1a and NKCC1b (Randall et al. 1997; Vibat et al. 2001; Morita et al. 2014). NKCC1b 
is highly expressed in the adult brain and constitutes up to ~80% of the total NKCC1 transcript in the 
human CNS (Vibat et al. 2001). NKCC1 has been suggested to undergo a global down-regulation 
during development in the rat and human brain (Plotkin et al. 1997; Dzhala et al. 2005). However, this 
notion is confounded by the use of antibodies and probes insensitive to NKCC1b (cf. Puskarjov et al. 
2014a). In line with this, studies based on NKCC1b-compatible mRNA probes and antibodies have 
demonstrated an absence of developmental down-regulation of NKCC1 in the CNS of rodents and 
humans (Clayton et al. 1998; Sun and Murali 1999; Yan et al. 2001; Marty et al. 2002; Mikawa et al. 
2002; Wang et al. 2002; Hyde et al. 2011; Morita et al. 2014).  
 Indeed, on the basis of microarray data analysis with probes spanning both major human 
NKCC1 splice variants NKCC1a and NKCC1b (Vibat et al. 2001; Morita et al. 2014) we found that 
NKCC1 expression in all of the examined human brain regions undergoes developmental up-
regulation. This is in agreement with previously published data on the expression of NKCC1 
transcripts in the human hippocampus and prefrontal cortex (Hyde et al. 2011; Morita et al. 2014). 
This kind of a progressive up-regulation of NKCC1 does not conflict, as might be thought at first 
sight, with what is known about the development of GABAergic transmission. The extremely high 
input resistance (Rin) of neonatal neurons implies that conductive ‘loads’ of Cl
- must be very low (see 
Kaila et al. 2014a). Therefore, a density of plasmalemmal NKCC1 that is sufficient to maintain actions 
of GABA depolarizing in immature neurons might be functionally barely observable in mature 
neurons with their much lower Rin. Moreover, there is evidence for structural and functional 
heterogeneity of plasmalemmal NKCC1 expression in adult neurons. The axon initial segment, a 
































































compartment expressing NKCC1 but lacking KCC2, has been shown to be important for maintaining 
depolarizing (Szabadics et al. 2006; Khirug et al. 2008) but probably functionally inhibitory responses 
(Kaila et al. 2014a) to GABA in mature cortical principal neurons. Interestingly, NKCC1b, in contrast 
to NKCC1a, lacks the domain encoded by exon 21, which contains a di-leucine motif that has been 
implicated in the basolateral vs. apical targeting of NKCC1 in polarized epithelial cells (Kaila et al. 
2014a). However, further work is needed to establish the subcellular localization of the NKCC1 splice 
variants in neurons. 
 
Conclusions 
To sum up, our present work describes the developmental patterns of CCCs in the human brain from 
the fetal stage to senescence. To our knowledge this is the first systematic account of the 
spatiotemporal expression patterns of the entire SLC12 gene family and also of the genes encoding the 
α and β subunits of the Na-K ATPase in the human brain. This kind of information is crucial for 
attempts to translate the extensive amount of information gained from work on the wide spectrum of 
CCC functions in the developing and mature rodent brain (Ben-Ari et al. 2007; Blaesse et al. 2009; 
Kaila et al. 2014a) to humans. A point worth of emphasis is that CCCs are gaining an increasing 
amount of interest as potential drug targets (Gagnon et al. 2013; Töllner et al. 2014), especially with 
regard to the design of novel anticonvulsant drugs (Löscher et al. 2013b; 2013a). In this context, our 
data on the fetal onset of KCC2 expression in human supraspinal brain structures (see also Vanhatalo 
et al. 2005; Bayatti et al. 2008; Robinson et al. 2010; Hyde et al. 2011) refute the view (cf. Dzhala et 
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Fig. 1. Spatiotemporal expression patterns of SLC12A family in the human brain. 
The microarray expression data were analyzed for all 9 members of the SLC12 family in 16 brain 
regions and at 13 different developmental periods (see Suppl. Table 1). Five CCCs (SLC12A1 
[encoding NKCC2], SLC12A3 [NCC], SLC12A7 [KCC4], SLC12A9 [CIP1], SLC12A8 [CCC9]) were 
not expressed in the human brain in any region or at any period (Suppl. Fig. 1). Remaining four CCCs 
(SLC12A2 [NKCC1], SLC12A4-6 [KCC1-3]) exhibited diverse spatiotemporal patterns of expression. 
NKCC1 and KCC3 were expressed in all regions at all periods, while KCC1 and KCC2 had specific 
patterns of expression (for details see text). Yellow line represents border between expressed (right) 
and unexpressed (left) samples. Note that in the majority of neocortical regions the onset of KCC2 
expression occurs between 19 and 24 PCW. 
Fig. 2. Developmental expression pattern of KCC2 immunoreactivity in the neocortex. 
At 16 PCW no KCC2-immunoreactive (KCC2-ir) neurons were observed either in cortical plate (A) or 
subplate (F). KCC2-ir was present in the neocortex from 25 PCW onwards in both the cortical plate 
(B) and the subplate (G). KCC2-ir neurons at 33 PCW (C, H), 40 PCW (D, I) and 51 years (E, J). 
KCC2-ir was also present in the adult subcortical white matter interstitial neurons (H). Note the 
difference between KCC2-ir neuron (arrow in B) and staining artefact (asterisk in B). Bar = 100 µm. 
































































Fig. 3. Developmental expression pattern of KCC2 immunoreactivity in the hippocampus and 
the entorhinal cortex. 
KCC2-ir neurons were observed in the hippocampus (stratum pyramidale) and the entorhinal cortex 
(layer 3-5) at 25 PCW (A, E), 33 PCW (B, F), 40 PCW (C, G) and 13 months (D, H). Bar = 100 µm. 
Fig. 4. Spatiotemporal expression patterns of NTRK2 in the human brain. 
The microarray expression data were analyzed for NTRK2 (encoding TrkB) in 16 brain regions and at 
13 different developmental periods (see Suppl. Table 1). NTRK2 is expressed in all examined regions 
from 10 PCW. Note that expression pattern of NTRK2 follows up-regulation of KCC2 expression in 
the neocortex.  
Fig 5. Spatiotemporal expression patterns of ATP1A1-4 in the human brain. 
The microarray expression data were analyzed for all 4 ATP1A (encoding Na-K ATPase α subunits 
1-4) family members in 16 brain regions and at 13 different developmental periods (see Suppl. Table 
1). Three members of the family (ATP1A1-3) are expressed in the human brain, while ATP1A4 is not 
expressed in the human brain at any period. ATP1A1 starts to be expressed from 10 PCW throughout 
entire lifespan in all analyzed regions. ATP1A2 and ATP1A3 have opposite expression patterns. 
Expression pattern of ATP1A2 closely follows the expression pattern of SLC12A5 (cf. Fig. 1), while 
ATP1A3 has the opposite expression pattern (higher prenatal and lower postnatal level of expression). 
Fig 6. Spatiotemporal expression patterns of ATP1B1-4 in the human brain. 
The microarray expression data were analyzed for all four ATP1B (encoding Na-K ATPase β subunits 
1-4) family members in 16 brain regions and at 13 different developmental periods (see Suppl. Table 
1). Three members of the family (ATP1B1-3) are expressed in the human brain, while ATP1B4 is not 
expressed in the human brain at any period. ATP1B1 and ATP1B2 exhibit similar expression pattern as 
SLC12A5, while ATP1B3 exhibits similar expression pattern as ATP1A3 (higher prenatal and lower 
postnatal level of expression). 
































































Fig 7. Spatiotemporal expression patterns of SYP and DLG4 in the human brain 
The microarray expression data were analyzed for SYP (encoding synaptophysin) and DLG4 
(encoding PSD-95) in 16 brain regions and at 13 different developmental periods (see Suppl. Table 1). 
SYP AND DLG4 are expressed in all examined regions from 10 PCW. Note that expression pattern of 
SYP follows up-regulation of KCC2 expression in the neocortex. DLG4 is expressed at high levels 
throughout the development, however it undergoes upregulation which correlates with the SLC12A5 
upregulation. 
Fig 8. Spatiotemporal expression patterns of CAST, CAPN1, CAPN2 and CAPNS1 in the human 
brain. 
The microarray expression data were analyzed for CAST (encoding calpastatin), CAPN1 (encoding 
large subunit of calpain 1), CAPN2 (encoding large subunit of calpain 2) and CAPNS1 (encoding small 
subunit of calpains 1-2) in 16 brain regions and at 13 different developmental periods (see Suppl. 
Table 1). CAPN1 and CAPN2 are expressed continuously throughout entire lifespan with CAPN1 
exhibiting higher prenatal and CAPN2 higher postnatal levels of expression. Note that CAST exhibits 
very low expression levels especially during the prenatal period and is up-regulated in the postnatal 
period. CAPNS1 is expressed at high at high levels throughout entire lifespan. 
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Fig. 1. Spatiotemporal expression patterns of SLC12A family in the human brain.  
The microarray expression data were analyzed for all 9 members of the SLC12 family in 16 brain regions 
and at 13 different developmental periods (see Suppl. Table 1). Five CCCs (SLC12A1 [encoding NKCC2], 
SLC12A3 [NCC], SLC12A7 [KCC4], SLC12A9 [CIP1], SLC12A8 [CCC9]) were not expressed in the human 
brain in any region or at any period (Suppl. Fig. 1). Remaining four CCCs (SLC12A2 [NKCC1], SLC12A4-6 
[KCC1-3]) exhibited diverse spatiotemporal patterns of expression. NKCC1 and KCC3 were expressed in all 
regions at all periods, while KCC1 and KCC2 had specific patterns of expression (for details see text). Yellow 
line represents border between expressed (right) and unexpressed (left) samples. Note that in the majority 
of neocortical regions the onset of KCC2 expression occurs between 19 and 24 PCW.  
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Fig. 2. Developmental expression pattern of KCC2 immunoreactivity in the neocortex.  
At 16 PCW no KCC2-immunoreactive (KCC2-ir) neurons were observed either in cortical plate (A) or 
subplate (F). KCC2-ir was present in the neocortex from 25 PCW onwards in both the cortical plate (B) and 
the subplate (G). KCC2-ir neurons at 33 PCW (C, H), 40 PCW (D, I) and 51 years (E, J). KCC2-ir was also 
present in the adult subcortical white matter interstitial neurons (H). Note the difference between KCC2-ir 
neuron (arrow in B) and staining artefact (asterisk in B). Bar = 100 µm.  
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Fig. 3. Developmental expression pattern of KCC2 immunoreactivity in the hippocampus and the entorhinal 
cortex.  
KCC2-ir neurons were observed in the hippocampus (stratum pyramidale) and the entorhinal cortex (layer 
3-5) at 25 PCW (A, E), 33 PCW (B, F), 40 PCW (C, G) and 13 months (D, H). Bar = 100 µm.  
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Fig. 4. Spatiotemporal expression patterns of NTRK2 in the human brain.  
The microarray expression data were analyzed for NTRK2 (encoding TrkB) in 16 brain regions and at 13 
different developmental periods (see Suppl. Table 1). NTRK2 is expressed in all examined regions from 10 
PCW. Note that expression pattern of NTRK2 follows up-regulation of KCC2 expression in the neocortex.  
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Fig 5. Spatiotemporal expression patterns of ATP1A1-4 in the human brain.  
The microarray expression data were analyzed for all 4 ATP1A (encoding Na-K ATPase α subunits 1 4) family 
members in 16 brain regions and at 13 different developmental periods (see Suppl. Table 1). Three 
members of the family (ATP1A1-3) are expressed in the human brain, while ATP1A4 is not expressed in the 
human brain at any period. ATP1A1 starts to be expressed from 10 PCW throughout entire lifespan in all 
analyzed regions. ATP1A2 and ATP1A3 have opposite expression patterns. Expression pattern of ATP1A2 
closely follows the expression pattern of SLC12A5 (cf. Fig. 1), while ATP1A3 has the opposite expression 
pattern (higher prenatal and lower postnatal level of expression).  
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Fig 6. Spatiotemporal expression patterns of ATP1B1-4 in the human brain.  
The microarray expression data were analyzed for all four ATP1B (encoding Na-K ATPase β subunits 1-4) 
family members in 16 brain regions and at 13 different developmental periods (see Suppl. Table 1). Three 
members of the family (ATP1B1 3) are expressed in the human brain, while ATP1B4 is not expressed in the 
human brain at any period. ATP1B1 and ATP1B2 exhibit similar expression pattern as SLC12A5, while 
ATP1B3 exhibits similar expression pattern as ATP1A3 (higher prenatal and lower postnatal level of 
expression).  
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Fig 7. Spatiotemporal expression patterns of SYP and DLG4 in the human brain  
The microarray expression data were analyzed for SYP (encoding synaptophysin) and DLG4 (encoding PSD-
95) in 16 brain regions and at 13 different developmental periods (see Suppl. Table 1). SYP AND DLG4 are 
expressed in all examined regions from 10 PCW. Note that expression pattern of SYP follows up-regulation 
of KCC2 expression in the neocortex. DLG4 is expressed at high levels throughout the development, 
however it undergoes upregulation which correlates with the SLC12A5 upregulation.  
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Fig 8. Spatiotemporal expression patterns of CAST, CAPN1, CAPN2 and CAPNS1 in the human brain.  
The microarray expression data were analyzed for CAST (encoding calpastatin), CAPN1 (encoding large 
subunit of calpain 1), CAPN2 (encoding large subunit of calpain 2) and CAPNS1 (encoding small subunit of 
calpains 1-2) in 16 brain regions and at 13 different developmental periods (see Suppl. Table 1). CAPN1 and 
CAPN2 are expressed continuously throughout entire lifespan with CAPN1 exhibiting higher prenatal and 
CAPN2 higher postnatal levels of expression. Note that CAST exhibits very low expression levels especially 
during the prenatal period and is up-regulated in the postnatal period. CAPNS1 is expressed at high at high 
levels throughout entire lifespan.    
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Supplementary Figure 1. Spatiotemporal expression patterns of SLC12A family in the human 
brain. 
The microarray expression data were analyzed for all 9 members of the SLC12 family in 16 brain 
regions and at 13 different developmental periods (see Suppl. Table 1). Five CCCs (SLC12A1 
[encoding NKCC2], SLC12A3 [NCC], SLC12A7 [KCC4], SLC12A9 [CIP1], SLC12A8 [CCC9]) were 
not expressed in the human brain in any region or at any period. For details see the main text. 
 






























































Supplementary Figure 2. Double-labeling immunocytochemistry for KCC2 and NeuN. 
Positive NeuN (dark nucleus) and KCC2 (brown cell bodies) cells can be observed in all brain regions. 
After 25 PCW numerous double stained neurons can be observed in the human brain. Images represent 
33 PCW specimen with substantial number of KCC2 and NeuN positive cells. Antibodies used KCC2 
(as described in the main text; 1:1000), NeuN – monoclonal mouse-anti-NeuN (1:500; Millipore 
Corporation, CA, USA) according to the standard protocol. 
 






























































Supplementary Figure 3. Developmental expression pattern of KCC2 immunoreactivity in the 
cingulate cortex. 
KCC2-ir was present in the cingulate cortex from 25 PCW onwards in both the cortical plate (A) and 
the subplate (E). KCC2-ir neurons at 33 PCW (B, F), 40 PCW (C, G) and 51 years (D, H). Note that 
KCC2-ir was present in the adult subcortical white matter interstitial neurons (H). Bar = 100 µm. 
 






























































Supplementary Figure 4. Developmental expression pattern of KCC2 immunoreactivity in the 
thalamus.  
Strong KCC2-ir in neuronal bodies and proximal dendritic shafts was observed in thalamus from 22 
PCW onwards (A). Note that the basic pattern of KCC2-ir thalamic neurons (the reactivity of cell 
body and proximal dendrites) remains similar from midfetal period to the birth, i.e. at 25 PCW (B), 27 
PCW (C), 33 PCW (D), 36 PCW (E) and 40 PCW (F). Bar = 100 µm. 
 






























































Supplementay Figure. 5. Developmental expression pattern of KCC2 immunoreactivity in the 
basal ganglia. 
Neurons in the globus pallidus display strong KCC2-ir in their cell body and proximal dendritic shafts 
at 22 PCW (A). At 33 PCW (B) and 40 PCW (C), the KCC2-ir also extends into distal dendrites of 
pallidal neurons. KCC2-ir neurons were also observed at 40 PCW in the claustrum (D), nucleus 
caudatus (E) and putamen (F). Bar = 100 µm. 
 






























































Supplementary table 1: Sixteen brain regions in which gene expression was analyzed, as previously 
defined (Kang et al. 2011). 
OFC Orbital prefrontal cortex 
MFC Medial prefrontal cortex 
DFC Dorsolateral prefrontal cortex 
VFC Ventrolateral prefrontal cortex 
M1C Primary motor cortex 
S1C Primary somatosensory cortex 
IPC Posterior inferior parietal cortex 
STC Superior temporal cortex 
A1C Primary auditory cortex 
ITC Inferior temporal cortex 
V1C Primary visual cortex 
AMY Amygdala 
CBC Cerebellar cortex 
HIP Hippocampus 
MD Mediodorsal nucleus of thalamus 
STR Striatum  
 































































Supplementary table 2: List of all brains analyzed by immunohistochemistry, with age and 
postmortem delay (PMD) 
CODE AGE PMD 
CF568 16 PCW 12 hours 
CF588 18 PCW 2 hours 
CD297 20 PCW 12 hours 
S40/09 20 PCW 6 hours 
CF599 22 PCW 24 hours 
F89/09 22 PCW 6 hours 
CD311 25 PCW 10 hours 
CD312 25 PCW 22 hours 
CD293 26 PCW 19 hours 
CF597 33 PCW 20 hours 
CF551 35 PCW 24 hours 
CF554 36 PCW 18 hours 
CF587 40 PCW 5 hours 
CD289 3 months 6 hours 
CD277 13 months 15 hours 
CD255 6.5 years 16 hours 
C0369 51 years 22 hours 






























































Supplementary table 3: Data matrix representing log2 transformed values of SLC12A1 (encoding for NKCC2) in different regions at different developmental 
periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value of 5.5 was used 
to determine expression status). 
3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 3.7554 3.71157 3.6237 3.64045 3.61539 3.70429 3.74229 3.72725 3.79393 3.79794 3.80321 3.9153 3.73844 
MFC 3.78655 3.69302 3.57746 3.68104 3.69536 3.7218 3.70494 3.74436 3.92492 3.86411 3.84206 3.80029 3.85507 
DFC 3.77996 3.70649 3.63396 3.68341 3.62418 3.63298 3.71051 3.72626 3.85803 3.76151 3.85101 3.95333 3.73338 
VFC 3.73734 3.746 3.59732 3.63911 3.68238 3.74562 3.68343 3.6544 3.90663 3.84855 3.8893 3.84639 3.78022 
M1C 3.73788 3.72914 3.65156 3.65913 3.65985 3.71064 3.84379 3.8244 4.0547 3.77279 3.87838 4.05997 3.81677 
S1C 3.69877 3.67827 3.72934 3.64711 3.63535 3.76723 3.8628 3.82844 4.08672 3.76677 3.85422 3.93655 3.82271 
IPC 3.78865 3.72167 3.63678 3.66921 3.66897 3.72562 3.85593 3.73666 3.69766 3.8291 3.84449 3.91397 3.77197 
STC 3.77636 3.82355 3.72252 3.65769 3.62176 3.60767 3.72803 3.76043 3.66445 3.76297 3.87801 3.9281 3.77017 
A1C 3.78966 3.75578 3.66014 3.68811 3.6388 3.66659 3.70266 3.70111 3.88334 3.82854 3.85696 3.83669 3.78654 
ITC 3.76307 3.82921 3.67105 3.62928 3.63029 3.69205 3.74063 3.80326 3.91603 3.80272 3.85575 3.97984 3.74513 
V1C 3.74097 3.73909 3.71251 3.58405 3.68984 3.71942 3.70921 3.6648 3.78961 3.84116 3.80851 3.80713 3.79307 
AMY 3.724 3.69122 3.61795 3.61336 3.65236 3.70405 3.85902 3.99338 3.90645 3.95074 3.82181 3.90172 3.86433 
CBC 3.71091 3.63967 3.53672 3.61645 3.66743 3.72984 3.69978 3.62961 3.86875 3.77761 3.83377 4.0154 3.85626 
HIP 3.6822 3.64451 3.66231 3.69538 3.77663 3.69331 3.80254 3.69024 3.79769 3.77855 3.85553 3.81931 3.82474 
MD 3.69095 3.7529 3.75435 3.66024 3.83731 3.7968 3.89286 3.69781 3.72015 3.98428 3.80886 3.86419 3.79869 
STR 3.75971 3.69356 3.70204 3.65572 3.68101 3.65385 3.81971 3.96005 3.8829 3.79879 3.88082 3.835 3.88226 
 






























































Supplementary table 4: Data matrix representing log2 transformed values of SLC12A3 (encoding for NCC) in different regions at different developmental 
periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value of 5.5 was used 
to determine expression status). 
3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 4.14593 4.11023 4.22177 4.03894 4.05362 4.09955 4.17289 4.11835 3.95334 4.01316 4.0657 4.1022 3.99122 
MFC 4.28329 4.18948 4.0633 4.14478 4.03062 4.10801 4.18099 4.02186 4.23323 3.98958 4.13843 4.14928 3.98565 
DFC 4.22414 4.24387 3.95382 4.14723 3.9936 4.04611 4.26391 4.0763 3.95955 4.00314 4.17724 4.01711 4.05923 
VFC 4.22779 4.28705 4.03974 4.10276 4.09443 4.11269 4.13085 3.98099 4.03346 4.05479 4.12213 4.01159 4.13431 
M1C 4.23383 4.33817 4.38108 4.20305 4.15169 4.03601 4.10717 4.23011 4.05592 4.02017 3.98789 4.03056 4.04902 
S1C 4.29692 4.28026 4.21521 4.12609 3.99492 4.09397 4.21718 3.87898 4.21362 4.01362 4.00312 4.04607 4.1718 
IPC 4.20187 4.15908 4.12078 4.06064 4.11538 4.09385 4.51337 3.93488 3.97471 4.06198 4.0084 4.07418 4.03087 
STC 4.29718 4.4455 3.97831 4.13007 4.12705 4.01311 4.21663 3.93061 3.98794 3.9915 4.0827 4.07706 4.02238 
A1C 4.18022 4.1423 4.15278 4.20996 4.08015 3.94813 4.03737 3.98845 4.10801 4.11077 4.11475 4.0321 4.03845 
ITC 4.37156 4.32748 4.23502 4.10206 4.15635 4.07169 4.31957 3.98391 3.96494 4.1381 4.04337 4.15544 3.92826 
V1C 4.24462 4.16284 4.13946 4.09824 3.99353 4.08095 4.22961 4.08044 4.1781 4.02819 3.98274 3.98285 4.07402 
AMY 4.11132 4.24669 4.16137 4.06518 4.02743 4.16986 4.18077 4.08129 4.07705 4.26414 4.06382 4.14456 4.04879 
CBC 4.05022 4.16486 3.89298 4.06743 4.20967 4.1773 4.12626 4.16641 4.20365 4.40455 4.10864 3.95627 3.96465 
HIP 4.20355 4.30764 4.04472 4.14025 3.97205 4.0942 4.05084 3.89053 4.18148 3.93799 4.047 3.98312 4.08271 
MD 4.21328 4.26972 3.97973 4.10437 4.31198 4.20349 4.35935 4.13262 4.13448 4.29567 3.94449 4.07272 4.12587 
STR 4.22788 4.23848 4.0502 4.03303 4.16922 4.00419 4.30387 4.1521 4.03387 4.14527 4.02067 3.97748 4.2425 






























































Supplementary table 5: Data matrix representing log2 transformed values of SLC12A7 (encoding for KCC4) in different regions at different developmental 
periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value of 5.5 was used 
to determine expression status). 
3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 5.01312 4.83304 4.58853 4.42653 4.94365 4.8735 4.99554 5.1244 5.52543 5.36269 5.0838 5.50416 5.08369 
MFC 5.14246 5.25735 5.06023 4.45202 5.14349 5.11059 4.86963 5.25774 5.0769 5.59082 5.04929 5.03459 4.98822 
DFC 4.96743 4.61892 4.52869 4.36029 5.13367 4.90375 5.05597 5.47466 5.25387 5.37184 5.1387 5.00693 5.05244 
VFC 4.89715 4.50368 4.67298 4.42235 4.62457 4.76289 4.72238 5.40846 5.36714 5.44796 5.22097 5.46339 4.94269 
M1C 4.82361 4.56573 5.27709 4.58373 4.79145 5.1259 4.5993 5.5738 5.20757 5.55379 5.39184 5.11931 5.21084 
S1C 4.79227 4.76485 5.18942 4.5755 4.58659 5.0581 4.87519 5.28467 4.77283 5.42813 5.15193 5.36818 5.12283 
IPC 4.82361 4.76838 4.52746 4.26569 5.04124 4.83721 5.33824 5.43892 5.25157 5.75165 5.25647 5.19252 5.18255 
STC 4.90086 4.67347 4.8131 4.2636 4.91681 4.84273 5.06478 5.33738 5.07068 5.36383 5.22282 5.22721 5.23883 
A1C 4.80132 4.75296 4.25659 4.1971 4.49646 5.11223 5.19978 5.41068 4.72116 5.46202 5.27812 5.07403 5.1023 
ITC 4.87265 4.71889 5.0214 4.39129 4.87734 4.82009 4.7914 5.44335 5.13042 5.58349 5.36536 5.45796 5.23049 
V1C 5.9065 5.43345 4.70502 4.52453 4.61595 5.26991 5.06244 5.234 5.08155 5.15317 5.1934 5.53567 5.26265 
AMY 5.29324 5.4763 5.26783 4.77069 4.96718 5.06313 4.77778 4.97413 4.89312 4.95084 4.89073 5.23478 4.78721 
CBC 5.42222 5.24113 4.92769 5.01765 5.10716 4.78074 4.68047 4.53764 4.52942 4.92181 4.98654 4.53593 4.82662 
HIP 6.00811 5.54762 5.24371 4.88189 5.21033 5.19466 5.46604 5.26712 5.11654 5.10477 5.3029 5.06462 5.45363 
MD 5.49497 5.62514 5.02202 4.82226 5.63542 5.03878 5.00829 5.48768 5.58771 5.11771 5.28904 5.71685 5.20404 
STR 7.34851 6.42964 5.86598 5.12657 5.3078 5.22574 5.05162 5.17524 4.89655 5.24264 5.23581 5.71376 5.14898 






























































Supplementary table 6: Data matrix representing log2 transformed values of SLC12A8 (encoding for CCC9) in different regions at different developmental 
periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value of 5.5 was used 
to determine expression status). 
3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 4.82804 4.71403 4.74762 4.97741 4.97768 4.88635 4.95152 4.45034 4.66731 4.74898 4.76535 4.71845 4.708 
MFC 4.92081 4.7354 4.81373 4.95744 4.63042 4.83566 4.99056 4.63858 4.5854 4.76656 4.81667 4.92713 4.7737 
DFC 4.73183 4.64135 4.98465 4.94244 4.8125 4.94841 4.81236 4.74416 4.86853 4.78532 4.9343 4.79685 4.98179 
VFC 4.88625 4.72274 4.98627 5.0842 4.67607 4.41639 4.77223 4.61985 4.76342 4.79839 4.99418 4.86439 4.9255 
M1C 4.70601 4.82163 5.12767 4.82481 4.50859 4.73276 4.8971 4.48117 4.99984 4.88521 4.81076 4.79811 4.74949 
S1C 4.8016 4.84579 4.91014 4.93418 4.82228 4.86482 4.74848 4.58432 4.52162 4.73945 4.8663 4.68848 4.79002 
IPC 4.88683 4.84518 4.92315 5.03947 4.62046 4.78028 5.24873 4.86173 4.80304 4.85715 4.77689 4.90375 4.64303 
STC 4.7957 4.78308 5.22617 4.96171 4.69168 4.61233 4.78004 4.61872 4.42717 4.64913 4.85131 4.67916 4.67423 
A1C 4.89682 4.73827 5.02378 4.9293 4.82008 4.86072 4.83761 4.88039 4.86019 4.70489 4.75433 4.79806 5.01252 
ITC 4.90641 4.86361 5.04003 4.74132 4.72954 4.58012 4.67188 4.61977 4.64289 4.84366 4.76959 4.60856 4.82449 
V1C 4.74097 4.7999 5.03571 4.93177 4.57165 4.70337 4.52546 4.70629 4.57156 4.73241 4.89358 4.88245 4.85755 
AMY 4.79526 4.83927 4.90483 4.93252 4.67914 4.89672 4.81206 4.59935 4.80312 4.72848 4.85463 4.68255 4.90312 
CBC 4.72495 4.63608 4.93242 4.93752 5.02766 5.16045 4.8625 4.95089 4.89093 5.02418 4.81277 4.95163 4.70545 
HIP 4.6617 4.73387 4.90468 4.9213 4.58345 4.92794 4.90347 4.77291 5.09777 4.77784 4.87989 4.77065 4.83011 
MD 4.65631 4.66013 4.97086 4.90941 4.84987 4.92616 4.75411 4.8804 4.621 4.92166 4.94893 4.7306 4.8188 
STR 4.83591 4.68029 4.93337 4.84742 4.5442 4.78138 4.93519 4.88475 4.61684 4.88115 5.01395 4.91473 4.96945 
 






























































Supplementary table 7: Data matrix representing log2 transformed values of SLC12A9 (encoding for CIP1) in different regions at different developmental 
periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value of 5.5 was used 
to determine expression status). 
3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 4.19876 4.17324 4.14132 4.24167 4.4033 4.63225 4.61989 4.63439 4.91137 5.12896 4.84624 4.93742 4.77963 
MFC 4.18238 4.25697 4.32191 4.13067 4.32838 4.81769 4.98116 4.63249 4.69202 5.34889 5.03806 4.6875 4.88302 
DFC 4.28111 4.22814 4.25999 4.15437 4.33645 4.9698 4.87477 4.51303 5.05866 5.21902 4.85438 4.99836 5.00644 
VFC 4.13969 4.13199 4.13683 4.12003 4.44417 4.87552 4.88938 4.76236 4.85277 5.1879 4.7396 4.97656 4.61496 
M1C 4.29611 4.33276 3.94507 4.20988 4.23975 4.64797 5.13722 4.56474 4.99483 4.94674 4.73852 4.88549 4.75968 
S1C 4.22599 4.28793 3.93738 4.23975 4.44302 5.04722 4.81349 4.69148 4.96144 5.0521 4.93318 4.92417 4.68504 
IPC 4.2177 4.29318 4.15675 4.25949 4.4688 4.61938 5.15696 4.63471 4.60393 5.1853 4.85158 4.82906 4.84113 
STC 4.18785 4.15449 4.13139 4.18526 4.26893 4.80839 4.88947 4.8506 4.5647 4.95123 4.86869 5.10557 4.75967 
A1C 4.06362 4.20535 4.11599 4.11712 4.26184 4.69834 4.75524 4.88093 4.63183 5.08492 4.80146 4.97903 4.81853 
ITC 4.04713 4.14451 4.23768 4.16277 4.38099 4.63729 4.76838 4.70614 4.59456 5.02369 4.84163 4.67236 4.89908 
V1C 4.20883 4.29117 4.21019 4.21953 4.48434 4.66361 5.10563 4.88723 4.88139 5.15105 5.07843 5.25533 5.06359 
AMY 4.14996 4.18556 4.42459 4.10098 4.39992 4.43724 4.77534 4.82626 4.50586 4.83263 4.98134 4.92692 4.89321 
CBC 4.11495 4.08187 4.2835 4.29244 4.41783 4.64621 4.21324 3.97299 4.06578 3.97619 4.05931 4.48166 4.11096 
HIP 4.37767 4.56109 4.20689 4.38738 4.56476 4.76627 4.98612 4.81905 4.83291 4.65995 5.2018 4.97336 5.12927 
MD 4.35634 4.17897 4.37391 4.66305 4.47493 4.53583 4.94187 4.543 4.53672 4.65384 4.49768 4.62512 4.54796 
STR 4.6088 4.298 4.9793 5.19028 4.6016 5.11354 5.2274 5.26197 5.21671 5.09192 5.04082 5.25116 5.08675 






























































Supplementary table 8: Data matrix representing log2 transformed values of SLC12A2 (encoding for NKCC1) in different regions at different developmental 
periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value of 5.5 was used 
to determine expression status). 
3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 6.98535 6.98629 7.60412 7.94765 7.16327 7.68799 8.87072 8.33796 9.45084 8.33358 8.71252 8.71916 8.74816 
MFC 6.39635 6.61482 7.282 7.80283 6.35986 7.29303 8.36417 8.37362 8.81177 8.20485 8.47291 8.87784 7.75838 
DFC 6.83813 6.37018 7.28087 7.64904 6.98979 7.66483 8.186 8.54093 7.9447 8.50575 8.86764 7.86239 8.50687 
VFC 7.18997 6.75843 8.0992 7.74827 6.60968 7.3938 8.55099 8.98336 8.73958 8.82013 9.05185 8.81476 8.49023 
M1C 6.73473 6.64061 6.60012 7.42586 6.70186 7.92329 8.31948 8.76354 8.94145 9.09611 9.02499 7.97869 8.88048 
S1C 6.94788 6.30039 6.21409 7.09893 6.23241 7.35674 7.9895 8.30369 8.63348 8.75079 8.84372 8.7168 8.24488 
IPC 6.72878 6.44794 6.36113 6.96242 6.57446 7.97589 7.36539 8.01132 9.26853 8.63448 8.61976 8.32144 8.25554 
STC 6.67399 6.22654 6.8506 6.84729 6.48133 7.72307 7.75612 7.89913 8.20631 8.28193 8.79241 7.69904 7.84486 
A1C 6.90573 6.88014 6.45799 6.66443 6.69879 7.99041 7.80742 7.93724 8.70793 8.76843 9.18719 8.21652 8.37484 
ITC 6.7634 6.38421 6.51981 6.2778 6.07825 6.48987 7.53334 8.23302 8.19902 8.4771 8.24559 7.74971 7.65709 
V1C 6.59038 6.41338 7.14135 7.28846 6.80953 7.7155 7.62905 8.34994 9.20024 8.07754 8.97771 8.28656 8.25825 
AMY 7.35276 7.01901 6.48314 7.15662 6.3087 7.17525 8.33345 7.6864 8.83261 8.86745 8.7813 7.40085 7.92558 
CBC 6.68149 6.25075 7.40906 6.78993 6.21315 8.40818 8.19922 8.51948 8.62549 8.68883 8.07365 7.20479 7.63316 
HIP 6.79653 6.21306 6.451 6.37122 6.33515 7.13354 8.35664 9.05542 8.47839 8.67785 8.70929 8.35128 7.98782 
MD 7.80973 7.82026 7.79034 7.82079 6.57676 8.43324 8.46109 8.87625 8.95491 9.24688 9.25685 9.3618 8.5964 
STR 6.49716 6.90962 6.21043 6.28767 6.35917 8.06653 7.99464 8.85336 7.49248 8.72337 9.43302 8.81863 8.15178 






























































Supplementary table 9: Data matrix representing log2 transformed values of SLC12A6 (encoding for KCC3) in different regions at different developmental 
periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value of 5.5 was used 
to determine expression status). 
3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 9.10494 8.83637 8.58099 8.09215 8.00167 7.44032 7.35013 6.76722 7.92779 7.8034 8.08972 7.8361 7.81557 
MFC 9.19531 8.68236 8.60026 8.37448 7.82983 7.34802 7.5225 6.87304 7.92775 7.5781 7.84869 7.41301 7.77327 
DFC 9.04188 9.04714 8.51788 8.23626 8.03928 7.90955 7.42611 7.17331 7.85003 7.94623 8.0242 7.46093 7.65113 
VFC 9.04656 8.952 8.37313 8.27394 7.91546 7.51361 7.4722 7.55572 8.0267 7.93074 8.33458 7.85752 7.46519 
M1C 9.1726 9.25624 8.56947 8.40021 7.89262 7.75501 7.60874 7.31396 7.23614 8.03854 8.387 7.43227 8.00421 
S1C 9.1198 9.13606 8.52005 8.54189 7.97147 6.88203 7.20138 7.63422 7.59929 8.06209 8.03851 8.0328 7.79505 
IPC 8.94473 9.13108 8.47428 8.45467 8.07767 7.77916 7.21219 7.12575 8.08741 7.94659 8.22415 7.57099 7.65202 
STC 9.0032 8.45871 8.30859 8.49798 8.09271 7.45334 7.12537 7.03566 7.14565 7.58551 8.02651 7.71739 7.70659 
A1C 8.81662 8.68002 8.21586 8.13332 8.37467 7.52016 7.95469 7.27628 7.80866 7.60076 8.28657 7.74594 7.77122 
ITC 8.58714 8.63461 8.39149 8.20257 8.08921 7.22651 7.07551 6.59858 7.78295 8.04763 8.10832 7.22492 7.64964 
V1C 9.16136 8.87762 8.4876 8.60625 7.6683 7.93373 7.43782 7.28817 8.29504 7.41911 8.28886 7.81184 7.36302 
AMY 8.37031 8.75509 8.31573 8.61388 7.50713 7.61663 7.93381 6.86261 8.07289 7.52053 8.07244 7.1855 7.10876 
CBC 9.01103 8.74308 8.1904 7.84976 7.26902 6.93967 7.20925 7.03898 7.82315 7.36702 7.85163 6.86622 6.98123 
HIP 8.35909 8.17469 8.41604 8.01098 7.46448 7.56441 7.19353 7.41988 7.83939 7.77465 7.71626 7.16613 6.91561 
MD 8.33061 8.09533 8.2209 7.75206 7.39755 7.09641 7.08195 7.12008 7.92055 7.38381 7.72242 7.62887 7.03711 
STR 8.75959 8.68762 8.84648 8.58988 7.57516 7.18016 8.03948 7.31224 7.19592 7.91723 8.21575 7.63653 7.21742 






























































Supplementary table 10: Data matrix representing log2 transformed values of SLC12A4 (encoding for KCC1) in different regions at different developmental 
periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value of 5.5 was used 
to determine expression status). 
3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 4.43723 4.84044 4.58183 4.59162 4.96352 5.55146 5.35699 5.63969 5.32169 5.41471 5.15351 5.31624 5.08195 
MFC 4.21519 4.93892 4.75664 4.45181 5.22482 5.60962 5.2186 5.91506 5.0707 5.64455 5.13615 5.33158 5.46074 
DFC 4.39099 4.54323 4.57473 4.35249 5.12312 5.31367 5.02216 5.72497 5.31427 5.31433 5.09131 5.09227 5.0697 
VFC 4.29605 4.28554 4.41846 4.33857 5.05965 5.42977 5.16667 5.49201 5.15066 5.56751 5.15635 5.26296 5.39279 
M1C 4.38549 4.25569 4.48415 4.47836 5.07446 5.39171 5.15678 5.76242 4.94004 5.48492 4.91768 5.04168 5.28489 
S1C 4.26077 4.17488 4.65996 4.44521 5.1399 5.40375 4.9951 5.49241 4.94413 5.3589 5.03865 5.16826 5.21 
IPC 4.21311 4.31281 4.08297 4.35145 5.32062 5.32538 4.96102 5.43829 5.03198 5.39284 5.00946 5.0924 5.40842 
STC 4.33248 4.39752 4.52396 4.40762 4.8403 5.33632 5.04212 5.15221 5.0888 5.20432 4.95357 5.04956 5.06319 
A1C 4.26888 4.4571 4.10593 4.33415 4.89684 5.52541 4.98332 5.74122 5.22026 5.38497 5.11913 5.08978 4.97056 
ITC 4.43918 4.55371 4.75601 4.49667 5.1538 5.46411 5.25635 5.79963 5.22731 5.42705 5.10076 5.21773 5.29584 
V1C 4.64992 4.76782 4.69826 4.35825 4.93019 5.62854 5.08916 5.27468 5.10712 5.71838 4.9271 5.01295 5.14085 
AMY 5.0923 5.50973 5.18684 5.07585 5.46026 5.47885 5.49911 5.43409 5.36766 5.46951 5.27999 5.40993 4.93025 
CBC 5.67487 5.84785 6.77145 7.10479 6.83319 6.89119 6.03416 6.43441 6.57643 6.22777 5.7431 5.52013 5.91953 
HIP 5.05789 5.39171 5.31997 5.10124 5.66531 5.90416 5.99572 5.58179 5.21144 5.74991 5.46293 5.38835 5.55425 
MD 4.71475 4.88352 4.8775 5.08857 5.48981 5.97328 6.04725 5.7991 6.01833 5.99121 5.65399 6.06745 5.9883 
STR 4.6854 5.0146 4.77463 5.13611 6.22134 5.99164 5.32236 5.36281 5.69435 5.66282 5.32151 5.58872 5.35589 






























































Supplementary table 11: Data matrix representing log2 transformed values of SLC12A5 (encoding for KCC2) in different regions at different developmental 
periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value of 5.5 was used 
to determine expression status). 
3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 4.5053 4.71418 4.8001 5.66918 6.96302 8.87889 8.98047 7.82262 9.37508 9.80537 9.68272 9.53576 9.58455 
MFC 4.37181 4.60274 4.57775 5.68318 6.58366 9.08761 8.92819 8.16594 9.37828 9.1281 9.34644 9.01847 9.5783 
DFC 4.4446 4.5834 4.82656 5.12368 7.14991 9.10092 9.13021 8.46023 9.63056 9.75089 9.59383 9.47026 9.6149 
VFC 4.66229 4.84501 5.20782 5.95644 6.99045 8.81244 9.29108 8.86446 9.49876 9.7535 9.75921 9.58684 9.5945 
M1C 4.8262 4.92092 5.52939 6.67414 7.33539 9.28139 9.59415 9.22906 9.19489 9.57476 9.79509 9.53261 9.94104 
S1C 4.58287 4.92795 5.12113 6.46389 7.28482 8.96711 9.16126 8.71638 9.4184 9.71419 9.88503 9.69505 9.75413 
IPC 4.38649 4.82228 5.20193 5.56942 7.06277 9.0722 9.1445 8.65192 8.89316 9.84682 9.9129 9.53474 9.86231 
STC 4.39806 4.46107 4.92584 5.73187 6.92797 8.95281 9.06021 8.49508 9.15411 9.44732 9.80087 9.53617 9.88072 
A1C 4.59313 4.84197 4.80783 5.65239 6.88574 9.21657 9.69608 8.34762 9.49567 9.42701 9.85287 9.82834 9.80544 
ITC 4.63073 4.41793 5.18336 5.95036 6.98881 8.66713 8.86184 8.88335 9.44343 9.5511 9.61948 9.51339 9.63107 
V1C 4.19365 4.1749 4.37473 5.03174 6.9706 9.35499 9.18778 8.95956 10.0851 9.29432 10.0639 10.2027 9.51023 
AMY 6.00117 5.75655 6.0188 5.98613 6.45575 8.81714 9.34379 8.34858 9.61514 9.37001 9.17763 7.59156 8.69257 
CBC 6.16913 5.69862 6.20509 5.47125 5.88129 8.17855 9.2319 9.43178 9.70835 10.1541 10.1123 9.69621 9.36619 
HIP 4.07 4.16168 5.64545 6.03194 5.86655 8.88693 9.09826 9.01589 9.45733 9.22645 9.16488 9.10873 9.15447 
MD 7.41907 7.92677 8.25428 8.40721 7.86815 9.4631 9.30732 9.32486 9.47366 9.69207 9.60167 9.48179 9.17847 
STR 5.46498 5.25956 6.98657 6.5452 4.42198 8.98661 9.59023 8.45992 8.8401 9.63167 9.31692 9.14059 9.31565 
 






























































Supplementary table 12: Data matrix representing log2 transformed values of NTRK2 (encoding for TrkB) in different regions at different developmental 
periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value of 5.5 was used 
to determine expression status). 
Area 3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 8.24209 8.5698 9.1499 10.2156 10.639 11.2415 11.3328 10.8392 11.6144 11.4602 11.4002 11.3161 11.45 
MFC 8.71701 8.7412 8.51099 9.63908 10.2051 11.1163 11.4094 11.0582 11.5599 11.3274 11.394 11.2027 11.3558 
DFC 8.146 8.17345 8.5908 9.84147 10.4999 11.2177 11.3602 11.3316 11.4401 11.2064 11.1293 11.4728 11.4 
VFC 8.61339 9.03061 9.4454 10.0744 10.4134 11.2314 11.3824 11.0933 11.7454 11.3835 11.1748 11.3619 11.2874 
M1C 9.13792 8.86381 9.62661 10.0108 10.1514 11.3298 11.2389 11.1333 11.4286 11.2185 11.125 11.2642 11.2634 
S1C 9.71042 9.40595 10.1783 10.1345 10.6891 11.0749 11.3501 11.1139 11.5092 11.304 11.1851 11.1879 11.2848 
IPC 10.1107 10.3135 10.1834 10.2417 10.4337 11.2421 11.1673 11.5031 11.6864 11.3216 11.1987 11.5005 11.436 
STC 10.3896 10.5341 9.90781 10.4608 10.4938 11.4684 11.4405 11.1972 11.712 11.2776 11.1857 11.2664 11.4982 
A1C 10.322 10.3269 10.1887 10.4828 10.574 11.3685 11.2886 11.3481 11.5976 11.1454 11.2296 11.2145 11.3509 
ITC 10.2991 10.3435 10.009 10.2169 10.13 11.3834 11.3867 11.0689 11.6135 11.3378 11.3957 11.4272 11.4089 
V1C 9.08563 9.321 10.2275 10.5748 10.6994 11.3945 11.0732 11.4289 11.4364 11.2197 11.0761 10.8946 10.8405 
AMY 10.4007 9.99086 9.86795 10.3523 10.8343 10.8414 11.1371 10.9387 11.1244 10.8869 11.0025 10.5898 10.8707 
CBC 9.65271 9.91398 10.4822 10.106 9.0022 9.73849 10.2638 10.3741 10.7115 10.4205 10.2939 9.93641 10.9619 
HIP 8.79377 8.64794 9.75119 10.2812 10.1463 10.9855 10.9232 10.7988 11.1548 10.7976 10.7747 11.1831 10.6643 
MD 10.1736 9.6263 10.0147 10.1391 10.8663 10.9257 11.2656 11.0112 10.9534 10.8831 10.9796 10.8592 11.0104 
STR 10.0183 10.1201 10.1711 10.1816 10.2038 10.506 11.375 10.7095 11.0426 10.6713 10.6434 10.7337 10.6492 
 






























































Supplementary table 13: Data matrix representing log2 transformed values of ATP1A1 (encoding for Na-K ATPase α1) in different regions at different 
developmental periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value 
of 5.5 was used to determine expression status). 
Area 3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 7.00198 7.03124 6.95638 7.1283 7.49084 8.07409 7.99485 7.30009 7.88273 8.25904 8.29566 8.11393 8.75434 
MFC 7.17649 7.54224 6.95086 7.30751 7.10628 7.772 7.60367 7.56471 8.69318 7.79339 7.59911 7.46094 8.23558 
DFC 7.16253 7.18768 6.46585 7.06783 7.48925 7.91897 7.93868 7.18113 8.08155 8.0812 8.01009 7.45777 8.06507 
VFC 7.03945 7.06472 7.2178 7.16934 7.20461 7.93516 7.81513 8.00577 7.97855 8.07136 8.6497 8.20569 8.98227 
M1C 7.15448 7.28157 7.34782 7.68914 7.4897 7.99063 7.70249 7.52606 8.2504 8.57677 8.90541 7.94934 8.84649 
S1C 7.37006 6.97985 6.71166 7.59668 7.5233 7.34818 7.82859 7.90203 8.56285 8.29568 8.72878 8.2533 9.09016 
IPC 6.80457 7.08725 7.44398 7.2487 7.08775 8.34574 7.65922 7.72188 8.23602 8.32366 8.43285 7.9209 8.65371 
STC 6.76953 6.64044 6.75583 7.35762 7.39587 7.33633 7.4617 7.53276 7.75761 8.07623 8.33424 8.21085 8.49292 
A1C 6.86316 6.74342 7.13443 7.25406 7.48828 7.76357 7.70555 7.79558 8.66361 8.22681 8.73277 8.06042 8.58255 
ITC 6.39708 5.98115 6.61488 7.00681 6.80044 7.5111 7.705 7.28597 7.79023 7.71065 8.07414 7.41589 8.07929 
V1C 6.72648 6.92457 6.64264 7.54321 7.65766 8.08741 8.49089 7.5753 9.09709 7.78278 8.67905 9.03846 8.54828 
AMY 6.53638 6.5486 6.87414 6.32804 6.38894 7.40199 7.48648 6.64793 7.39397 7.32002 7.64357 7.44553 7.15492 
CBC 6.91087 6.60172 6.70769 6.54044 7.96941 8.82969 9.36094 9.51959 8.7831 9.41226 9.15007 7.91306 8.12102 
HIP 6.24366 6.33912 6.8756 7.0808 5.98431 7.13438 7.17451 7.50392 7.85385 7.52607 7.60429 7.72929 8.36915 
MD 6.7367 6.70563 6.75925 6.92265 6.85156 7.42164 7.54092 8.18945 7.49513 7.53205 7.44823 7.45142 7.52329 
STR 6.79735 6.5484 6.97591 7.16713 6.37485 7.6593 7.46412 7.3841 7.50975 8.08257 7.97796 7.55329 7.91067 
 






























































Supplementary table 14: Data matrix representing log2 transformed values of ATP1A2 (encoding for Na-K ATPase α2) in different regions at different 
developmental periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value 
of 5.5 was used to determine expression status). 
Area 3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 6.37493 7.28397 6.66562 7.47304 9.05685 11.1255 10.7162 11.8623 10.7473 10.9836 10.5069 10.3862 10.8482 
MFC 5.52994 7.03891 7.62275 7.26543 9.50743 11.2676 10.6906 11.885 11.1055 11.1811 10.538 10.6214 10.9198 
DFC 5.54322 5.53076 6.91205 6.51581 9.15599 10.8874 10.501 11.6816 10.9301 10.9063 10.4195 10.3246 10.8203 
VFC 4.94142 4.6647 6.62299 7.0895 9.14382 10.8747 10.4567 11.3028 10.6189 11.1429 10.2399 10.3333 10.6558 
M1C 4.82689 4.83025 6.55572 7.44802 9.35386 11.2727 10.0981 11.6551 10.404 11.0944 10.3115 10.7186 11.1031 
S1C 4.85036 4.85975 6.89012 7.27124 9.16324 11.011 10.0796 11.8038 10.3681 11.3528 10.2338 10.6063 10.9237 
IPC 4.66677 4.82615 5.94221 6.52825 8.8512 10.9791 10.061 11.7518 10.4981 11.14 10.1528 10.5024 11.0581 
STC 4.8414 5.29278 6.7295 6.23711 8.64701 10.9243 10.4076 11.0898 10.7457 11.0687 10.357 10.368 10.9048 
A1C 4.80866 5.45409 5.06276 6.48925 8.65581 11.1756 10.4468 11.1203 10.4976 11.2439 10.1699 10.4915 11.0998 
ITC 5.1435 5.931 7.53028 7.26666 8.68428 10.9652 10.4848 11.6589 10.8939 11.0141 10.6175 10.5783 10.817 
V1C 5.76207 6.41418 7.02641 7.07571 8.76764 11.1247 10.0892 11.7967 10.2861 10.9594 10.1958 10.1075 10.621 
AMY 7.85479 8.22812 8.37066 9.50387 10.3106 11.2897 10.9824 11.2623 10.9565 10.9094 10.9652 11.0373 10.8345 
CBC 8.45464 8.57833 9.84716 9.78522 8.98986 10.4827 10.1516 10.4311 10.2784 10.7226 9.83627 9.53847 10.9008 
HIP 8.97498 9.25372 9.13197 9.49873 10.6861 11.5112 11.1188 11.2076 10.9231 11.3498 10.7155 10.8977 10.8416 
MD 7.32479 7.33196 7.87335 9.50415 10.1706 11.4154 11.1933 11.4726 11.6039 11.1704 11.031 11.4431 11.3661 
STR 5.97948 6.59547 8.27241 9.01657 10.6387 11.3108 10.9677 11.0484 10.5344 11.1091 11.131 11.0914 10.9273 
 






























































Supplementary table 15: Data matrix representing log2 transformed values of ATP1A3 (encoding for Na-K ATPase α3) in different regions at different 
developmental periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value 
of 5.5 was used to determine expression status). 
Area 3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 6.67933 6.83735 6.29035 6.50093 7.12775 6.41564 6.1484 4.84302 5.02612 6.05004 5.94631 5.71091 5.9491 
MFC 7.22345 7.32408 6.29181 6.37317 6.38128 6.48807 6.13416 5.52148 5.32458 6.09551 6.09003 5.78406 6.18842 
DFC 6.97662 7.48635 6.71353 6.25862 6.96469 6.48079 6.1418 5.11326 5.70698 6.15261 6.02296 5.7863 5.71084 
VFC 6.8996 7.16256 6.64509 6.62507 6.78342 6.33585 6.30533 5.37281 5.13605 6.36991 6.02669 5.70981 5.90064 
M1C 7.13845 7.50059 7.33021 6.6956 6.68795 6.49505 5.86587 5.82927 5.86361 5.65564 6.4018 6.47569 6.26492 
S1C 7.58804 7.234 7.02247 6.51658 6.89607 6.36296 6.26452 4.9397 5.11307 6.20935 6.44212 6.56405 6.06441 
IPC 7.37799 7.27476 6.58231 6.55779 7.45849 6.18961 6.09309 4.89618 5.25668 6.1134 6.47434 5.60511 6.12831 
STC 7.16553 7.08171 5.95421 6.51857 6.90165 6.13278 6.42119 4.99583 4.81209 5.96815 6.07272 5.98082 5.73637 
A1C 6.92299 6.97706 5.96768 6.44074 6.88489 6.0804 6.42339 5.53972 5.81108 5.80231 6.28525 5.57671 6.04963 
ITC 6.71239 7.02007 6.53804 6.35272 7.11662 6.74927 6.17377 5.58632 5.37496 5.79081 6.28109 5.37379 5.71132 
V1C 7.86832 7.68219 6.00607 6.35616 6.38746 6.65271 6.23952 5.54498 6.0322 6.21221 6.4172 6.48367 5.98717 
AMY 6.27535 6.57033 6.00106 5.89031 5.93269 6.38564 6.02046 5.70084 6.12111 5.76563 6.32481 5.18413 5.29933 
CBC 6.83522 7.54859 6.2319 6.62743 7.73155 7.04634 6.65029 5.35776 5.26291 6.29684 6.524 5.84758 6.11973 
HIP 6.3561 6.41598 6.03226 5.96859 5.8683 6.53501 6.01918 5.95092 6.65653 6.34312 6.61749 6.18779 6.38392 
MD 6.32928 6.61426 7.01519 6.31259 6.26489 6.99756 7.11161 6.86028 6.59464 7.26405 7.13246 6.79363 6.27351 
STR 6.82842 6.73576 6.10134 5.57036 5.36469 5.52801 5.57743 5.40497 5.22509 5.21706 5.43038 5.08329 5.16874 
 






























































Supplementary table 16: Data matrix representing log2 transformed values of ATP1A4 (encoding for Na-K ATPase α4) in different regions at different 
developmental periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value 
of 5.5 was used to determine expression status). 
Area 3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 3.61326 3.60755 3.57554 3.64812 3.67249 3.59857 3.70414 3.7242 3.67166 3.71423 3.65763 3.75634 3.68176 
MFC 3.62452 3.55595 3.59242 3.64306 3.66862 3.59929 3.69866 3.87273 3.55568 3.75121 3.63714 3.66879 3.59991 
DFC 3.61503 3.64134 3.6387 3.6443 3.84911 3.69134 3.67952 3.70022 3.66289 3.62697 3.72773 3.66904 3.74138 
VFC 3.59116 3.59611 3.6531 3.63769 3.67416 3.653 3.7812 3.61866 3.70256 3.62854 3.66234 3.58352 3.74935 
M1C 3.63204 3.66243 3.65992 3.63984 3.70244 3.6124 3.81693 3.57508 3.70379 3.57594 3.66302 3.72959 3.63023 
S1C 3.59494 3.71653 3.59913 3.62205 3.73515 3.68937 3.65763 3.68359 3.63359 3.65972 3.65209 3.64954 3.61547 
IPC 3.73576 3.64411 3.63785 3.64887 3.6567 3.64962 3.76607 3.63547 3.58417 3.58656 3.60809 3.7475 3.74963 
STC 3.57805 3.68168 3.65018 3.61289 3.67175 3.61812 3.80231 3.72339 3.71228 3.64541 3.71639 3.64449 3.62787 
A1C 3.57632 3.65005 3.6534 3.69142 3.60259 3.60863 3.81455 3.73694 3.59261 3.6499 3.64428 3.71332 3.66734 
ITC 3.6634 3.64993 3.65681 3.65041 3.64102 3.62179 3.73074 3.69708 3.69491 3.67775 3.66656 3.65525 3.64525 
V1C 3.65343 3.74466 3.62597 3.64381 3.65597 3.69334 3.70911 3.74111 3.75202 3.6029 3.67065 3.63088 3.68248 
AMY 3.65315 3.63502 3.58805 3.61738 3.84279 3.73899 3.64004 3.70763 3.64925 3.68879 3.69427 3.74383 3.73868 
CBC 3.56872 3.56229 3.60766 3.64856 3.69899 3.57544 3.65587 3.54702 3.62069 3.69219 3.61141 3.61881 3.63487 
HIP 3.61577 3.57553 3.63902 3.6423 3.7058 3.5861 3.7033 3.64448 3.67914 3.75676 3.66437 3.617 3.70904 
MD 3.61331 3.69508 3.58793 3.66406 3.76575 3.72579 3.63179 3.79537 3.74525 3.61189 3.67474 3.69987 3.6896 
STR 3.60149 3.67379 3.56502 3.59236 3.78666 3.70896 3.78903 3.70475 3.62308 3.61634 3.65156 3.71284 3.71602 
 






























































Supplementary table 17: Data matrix representing log2 transformed values of ATP1B1 (encoding for Na-K ATPase β1) in different regions at different 
developmental periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value 
of 5.5 was used to determine expression status). 
Area 3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 8.05368 7.974 8.60149 8.88919 9.40524 10.0495 10.2853 9.07689 10.2249 10.4169 10.1902 10.2389 10.3584 
MFC 8.21854 8.33066 8.28429 9.33013 9.00967 10.1757 10.1759 8.80725 10.1355 10.121 10.1042 10.0037 10.3034 
DFC 8.06041 8.20403 8.3347 9.03438 9.27477 10.1573 10.2928 9.23244 9.71685 10.2496 10.1261 10.0363 10.3814 
VFC 7.96744 8.13087 8.86523 9.29951 9.236 10.2207 10.3758 9.87602 10.1964 10.4597 10.244 10.1733 10.7973 
M1C 7.97321 8.19569 8.70333 9.63045 9.25609 10.1554 10.2341 9.33725 10.3451 10.5997 10.4292 10.4679 10.6991 
S1C 8.22248 8.14714 8.01431 9.78755 9.34451 10.1806 10.3475 9.00958 10.2234 10.5242 10.4963 10.6493 10.7608 
IPC 8.04814 8.20868 8.71677 9.33541 9.36292 10.376 10 9.16744 10.6546 10.4453 10.3933 9.94411 10.4002 
STC 8.07309 7.68753 8.64469 9.43145 9.6365 10.1217 10.1191 8.7945 9.99 10.2713 10.3112 10.2196 10.4526 
A1C 8.016 7.81454 9.10992 9.54717 9.3959 10.1374 10.2281 9.433 10.3032 10.4925 10.5145 10.3715 10.6301 
ITC 7.97855 7.9302 8.17468 9.15532 9.13998 10.1103 9.99053 8.56963 9.9754 9.97673 10.0966 9.99131 10.1473 
V1C 7.6671 7.59259 8.25983 8.93873 9.22182 9.93749 10.1984 9.30471 10.633 10.7661 10.441 10.3023 10.3027 
AMY 7.97845 8.102 8.27646 8.54958 8.93502 9.62199 9.89303 8.60795 10.3943 10.1708 9.69326 9.21528 10.0923 
CBC 8.17191 7.83948 8.65718 7.42172 7.63645 9.23108 9.42539 8.95965 9.61669 10.0159 10.0637 9.51739 9.93814 
HIP 7.99592 7.3653 8.51059 8.92058 7.33199 10.3238 9.85611 9.75193 10.7693 10.5241 10.4016 9.897 10.7133 
MD 8.77802 8.744 9.35018 9.3182 9.62664 10.4676 10.5339 10.1351 11.1659 10.7804 10.7408 10.6571 10.4168 
STR 7.62584 7.59082 8.11847 8.01578 7.6251 9.6711 9.38279 9.30682 9.62222 9.67762 9.88509 9.41022 9.53006 
 






























































Supplementary table 18: Data matrix representing log2 transformed values of ATP1B2 (encoding for Na-K ATPase β2) in different regions at different 
developmental periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value 
of 5.5 was used to determine expression status). 
Area 3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 9.64346 9.84122 9.96167 10.3597 11.412 12.0526 11.6256 12.4088 11.1176 12.0144 11.4724 11.2262 11.6024 
MFC 9.85731 9.6773 9.90841 10.5255 11.6095 11.9078 11.6127 12.5346 11.4327 12.2659 11.4998 11.48 11.8927 
DFC 9.74393 10.0764 9.43983 10.2289 11.585 11.8622 11.358 12.4786 11.3255 12.0805 11.3888 11.4153 11.5761 
VFC 9.6215 9.88664 9.68748 10.2716 11.4909 11.8273 11.6917 12.0584 11.366 12.2394 11.0584 11.0173 11.624 
M1C 9.96874 9.95659 10.1314 10.7831 11.7308 12.2522 11.2985 12.3521 11.057 12.2721 11.0235 11.3532 11.7217 
S1C 9.85622 9.82573 10.3421 10.5532 11.611 11.8728 11.0834 12.596 11.2311 12.3763 11.0849 11.3558 11.6377 
IPC 9.74008 10.1354 9.86428 10.4565 11.6403 11.9833 11.3524 12.4603 11.3973 12.1848 10.9995 11.2761 11.6097 
STC 9.89412 10.1335 9.51237 10.4895 11.4071 12.1342 11.4573 12.2263 11.4045 12.0172 11.2478 11.124 11.6119 
A1C 9.70474 10.017 9.40503 10.376 11.5 12.0955 11.2869 12.4223 11.1743 12.2592 10.9023 11.2488 11.4827 
ITC 9.60132 9.75787 9.93567 10.3752 11.2232 12.0688 11.6321 12.5865 11.7642 12.3665 11.6045 11.5601 11.6349 
V1C 10.0726 10.21 9.57451 10.2581 11.0852 11.9616 11.0972 12.4619 10.7967 12.4556 11.0548 11.0641 11.5841 
AMY 10.0929 10.3171 10.5353 11.1835 11.8406 12.3597 12.0573 12.2269 11.5935 12.0892 11.7317 11.6168 11.6307 
CBC 10.4649 10.5863 10.241 10.796 10.6485 11.8153 11.72 12.0826 11.9787 12.3861 12.1763 11.894 12.1902 
HIP 9.87324 10.3336 10.5053 10.796 11.6841 12.5634 11.9992 11.9209 11.3889 12.1796 11.4789 11.6155 11.7061 
MD 9.81282 10.3776 10.6582 11.1591 11.7319 12.5391 12.228 12.5358 12.504 12.2241 11.8775 12.2617 12.324 
STR 9.71967 9.61989 10.5751 11.1364 11.9717 12.353 11.9285 12.0714 12.0834 12.1085 11.7447 11.6634 11.7975 
 






























































Supplementary table 19: Data matrix representing log2 transformed values of ATP1B3 (encoding for Na-K ATPase β3) in different regions at different 
developmental periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value 
of 5.5 was used to determine expression status). 
Area 3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 5.80051 6.00555 6.41394 5.6133 6.5186 5.95826 6.38852 5.75789 5.42606 6.00342 5.80569 5.45866 6.14254 
MFC 6.03415 5.82103 6.7363 6.58925 6.75597 5.93856 6.14211 6.15511 5.09601 5.93705 6.10406 6.02026 5.96246 
DFC 6.04035 5.85234 6.7723 6.11121 6.65345 5.76969 5.97799 6.10018 5.51696 5.40178 5.35113 5.53228 6.09774 
VFC 5.85203 6.11297 6.92357 6.29437 6.75322 6.05137 5.77426 6.34526 5.79356 5.86784 5.60237 5.64525 6.18231 
M1C 6.22082 5.83192 6.33597 6.01857 6.9742 5.33221 5.66643 5.84993 6.08116 5.56531 5.94492 5.4367 5.99866 
S1C 6.30896 6.02188 6.54419 6.05588 6.89114 6.57803 5.90549 6.17838 5.75097 5.81166 6.04392 5.9839 6.26169 
IPC 6.34817 6.04365 6.51848 6.63114 6.85283 5.79696 6.22069 6.17827 5.57847 5.69979 5.55954 5.86351 6.26899 
STC 5.98219 6.02582 7.3234 6.81198 6.58526 6.84179 6.2249 6.12729 5.54925 5.81256 6.04823 5.97307 6.38609 
A1C 6.08684 5.84761 6.9606 6.06379 6.77818 6.40161 6.32669 6.48199 5.37254 5.91534 6.05488 5.90482 6.45349 
ITC 5.80017 5.846 6.25941 5.86197 6.62744 5.69482 6.24895 6.42329 5.6159 5.6493 5.98953 6.11272 6.26193 
V1C 6.84466 6.46795 6.6639 7.0061 6.75501 6.25184 5.94994 6.64866 5.28415 6.08954 6.09084 5.62578 6.30355 
AMY 6.16515 5.97426 6.52585 5.87108 6.53939 6.16339 5.12707 5.77209 5.66817 5.22466 6.19596 5.8179 6.01739 
CBC 5.18833 5.50317 6.56113 5.65827 7.36451 7.09292 7.33683 8.23296 6.31395 6.47136 6.48209 7.47465 7.45683 
HIP 5.91848 5.998 6.13431 6.09339 6.21225 6.37297 5.41238 5.78568 5.42328 5.76578 6.20828 5.69173 6.23234 
MD 5.65723 5.46326 6.63517 6.60217 7.15598 5.35024 6.28009 6.54925 6.47824 6.04252 5.68579 6.15562 5.86414 
STR 5.73456 5.87651 6.90592 6.79606 5.58483 6.57666 5.57384 6.37166 6.14436 6.42767 6.92091 6.48536 6.57116 
 






























































Supplementary table 20: Data matrix representing log2 transformed values of ATP1B4 (encoding for Na-K ATPase β4) in different regions at different 
developmental periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value 
of 5.5 was used to determine expression status). 
Area 3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 3.74003 3.7434 3.71499 3.6376 3.75049 3.72472 3.74574 3.90315 3.78427 3.70949 3.73803 3.6466 3.71806 
MFC 3.77205 3.75737 3.61085 3.65632 3.70337 3.73436 3.77688 3.88739 3.76264 3.74863 3.79172 3.78984 3.6781 
DFC 3.76109 3.76415 3.66354 3.70858 3.64536 3.69148 3.75843 3.85887 3.86724 3.73106 3.75874 3.83041 3.70038 
VFC 3.77262 3.69365 3.60918 3.66057 3.71793 3.77774 3.75401 3.70064 3.74816 3.72707 3.73871 3.77789 3.70331 
M1C 3.72015 3.75615 3.69621 3.7727 3.78391 3.74673 3.76437 3.91047 3.89289 3.70845 3.71529 3.79272 3.70218 
S1C 3.7386 3.83746 3.6264 3.63819 3.70831 3.8241 3.78759 3.77993 3.7159 3.77014 3.72216 3.68029 3.79682 
IPC 3.77754 3.73461 3.6282 3.70393 3.74065 3.79019 3.91688 3.86934 3.76658 3.75125 3.72783 3.74766 3.75966 
STC 3.74009 3.79557 3.68381 3.68997 3.68647 3.75657 3.75686 3.82681 3.78578 3.7042 3.66898 3.75473 3.759 
A1C 3.75704 3.83678 3.6472 3.71043 3.78654 3.73959 3.85501 3.73549 3.78972 3.81216 3.72905 3.76498 3.7385 
ITC 3.75158 3.79186 3.64751 3.71532 3.70237 3.74316 3.78847 3.81465 3.84365 3.73451 3.69708 3.78087 3.72511 
V1C 3.68652 3.75304 3.59984 3.67302 3.98734 3.81833 3.73762 3.80449 3.8899 3.80784 3.64763 3.70386 3.90737 
AMY 3.76666 3.65865 3.65624 3.68403 3.79499 3.78199 3.734 3.89851 3.81349 3.85456 3.75463 3.74239 3.89806 
CBC 3.7185 3.69754 3.60108 3.70037 3.82095 3.71796 3.73839 3.68928 3.709 3.64562 3.74904 3.87408 3.79147 
HIP 3.6576 3.69073 3.72308 3.68019 3.72827 3.82743 3.77899 3.71881 3.87146 3.7594 3.71071 3.85346 3.86855 
MD 3.81047 3.7159 3.70693 3.68461 3.9167 3.96379 3.82548 3.58875 3.71484 3.72139 3.68642 3.72293 3.82846 
STR 3.7736 3.74682 3.66413 3.66372 3.91917 3.68443 3.84316 3.84304 3.8189 3.74326 3.63552 3.70792 3.75308 
 






























































Supplementary table 21: Data matrix representing log2 transformed values of SYP (encoding for synaptophysin) in different regions at different 
developmental periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value 
of 5.5 was used to determine expression status). 
Area 3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 7.5755 7.61018 7.70192 8.29754 10.8426 11.6138 11.2109 10.9942 10.8495 11.0269 10.9777 10.4939 10.7259 
MFC 7.78979 7.75656 7.89149 8.5876 11.0715 11.5153 11.2357 11.1104 10.9899 10.795 11.0068 10.353 10.8444 
DFC 7.70799 7.65083 7.57055 8.22652 10.5674 11.3284 11.3714 11.2559 10.9301 10.8556 11.2015 10.194 10.7157 
VFC 7.66797 7.5905 8.33899 8.68926 10.6135 11.4487 11.256 11.056 10.7636 10.8858 10.8817 10.5413 10.7027 
M1C 7.96427 7.9315 8.14116 8.84777 11.2387 11.283 11.2071 11.3846 10.7275 10.8271 10.9603 10.3642 10.8267 
S1C 7.86941 8.01658 8.02218 8.97142 11.1292 11.4251 10.9856 11.1985 10.6718 10.8579 10.8365 10.5957 10.8109 
IPC 7.82329 7.95245 8.37055 8.71966 10.7016 11.2308 11.2487 11.4502 10.9878 10.9287 10.8288 10.6177 11.0091 
STC 7.76276 7.86805 7.99316 8.35085 10.6261 11.2517 11.2469 11.5059 10.7803 10.9006 11.0249 10.5475 10.8507 
A1C 7.7144 7.75419 8.16038 8.4601 10.5599 11.2867 11.5568 11.4093 10.8623 10.9387 10.75 10.3492 10.8274 
ITC 7.51039 7.78569 8.0853 8.52175 10.6339 11.2918 11.3016 11.31 10.774 10.8411 10.9757 10.5937 11.0055 
V1C 8.30968 8.29668 8.07472 8.08909 10.6413 11.1307 11.245 11.2969 10.707 10.9317 10.9781 10.7616 10.3051 
AMY 7.27442 7.12929 7.73534 7.81325 10.2925 11.0577 10.9663 10.9332 10.5749 10.797 10.7826 10.3474 10.8208 
CBC 7.59352 7.47088 8.67153 8.31307 9.10232 10.2814 9.90809 9.89017 9.37927 10.1247 10.5778 9.46112 9.74485 
HIP 7.00313 7.10552 8.40099 9.31575 10.2792 11.0506 10.7243 10.8491 10.7833 10.8191 10.8556 10.6875 10.878 
MD 8.57044 8.76038 9.64564 10.1933 11.0596 10.8835 11.0478 10.5464 10.9031 10.781 11.0476 10.8846 10.507 
STR 7.53613 7.28121 8.50181 8.3117 6.93301 9.44707 9.35145 9.60049 8.78553 9.08911 9.3896 8.92049 9.15804 
 






























































Supplementary table 22: Data matrix representing log2 transformed values of DLG (encoding for PSD-95) in different regions at different developmental 
periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value of 5.5 was used 
to determine expression status). 
Area 3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 9.87702 9.82039 9.74601 9.62339 10.1304 10.6326 10.7508 10.4896 9.94122 10.625 10.4472 10.5112 10.3023 
MFC 10.2713 10.035 9.55493 9.83635 9.6291 10.7629 10.8952 10.4154 10.3803 10.5102 10.6908 10.252 10.6866 
DFC 10.1266 9.94422 9.51958 9.78965 10.0694 10.8154 10.7866 10.556 10.6202 10.7612 10.5149 10.7402 10.4885 
VFC 9.84864 9.92176 9.40167 9.83534 10.1466 10.9199 10.8763 10.1266 10.2454 10.7374 10.3488 10.3186 10.135 
M1C 10.1303 10.2022 9.98845 10.0188 10.042 10.8756 11.1282 10.598 10.4103 10.5515 10.4192 10.5629 10.1883 
S1C 10.1802 10.0234 10.0166 9.93439 10.0656 10.5452 10.907 10.1145 10.6218 10.5729 10.4271 10.6445 10.0974 
IPC 10.0186 10.038 9.87377 9.95349 9.93133 10.925 11.1163 10.204 10.3452 10.5636 10.6367 10.6185 10.2172 
STC 10.043 10.0285 9.16774 9.60753 9.76262 10.8133 10.9044 10.5662 10.364 10.6781 10.3686 10.4361 10.1118 
A1C 10.0151 9.80571 9.63379 9.66658 9.79791 10.8315 10.8833 10.4344 10.476 10.6587 10.3765 10.3224 10.1457 
ITC 9.92903 9.95789 9.69268 9.60957 10.1046 11.0005 11.031 10.4031 10.6408 10.8003 10.5928 10.5922 9.97667 
V1C 10.4467 10.3878 9.72915 9.69769 9.52537 10.883 10.9464 10.2626 10.221 10.4878 10.3155 10.1065 9.67507 
AMY 9.76658 9.55075 9.26952 9.15762 9.16845 10.5508 10.4931 10.0247 10.2009 10.4223 10.1514 10.3926 10.0423 
CBC 9.71696 9.79224 8.85514 9.11604 9.30273 9.9283 9.80618 9.83742 10.103 10.3198 10.2805 10.109 10.2655 
HIP 9.59735 9.78292 9.66752 9.54255 9.10558 10.4957 10.6113 10.0854 10.2161 10.4478 10.2127 10.646 10.4189 
MD 9.76502 10.0032 9.68372 9.50092 8.68588 10.6323 10.3823 9.89519 10.3998 10.2588 9.79977 9.53426 9.48009 
STR 10.3273 9.83216 10.1075 9.78477 7.74497 10.4235 10.8963 10.609 11.5911 10.9014 10.4481 10.5311 10.6743 
 






























































Supplementary table 23: Data matrix representing log2 transformed values of CAST (encoding for calpastatin) in different regions at different developmental 
periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value of 5.5 was used 
to determine expression status). 
Area 3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 5.74053 5.63274 6.06237 5.65108 6.94823 7.07482 7.63212 8.31464 8.23316 8.36425 8.48855 8.4111 8.69943 
MFC 5.17142 5.51882 5.94255 6.06033 7.44019 7.41997 7.64332 8.17485 8.32197 8.4194 8.45511 8.40415 8.43723 
DFC 5.45619 5.38196 5.75039 5.52771 7.31307 7.19466 7.54747 8.15254 7.94675 8.56992 8.71432 8.2792 8.71587 
VFC 5.59061 5.30953 5.78823 5.76558 6.98829 7.12339 7.82931 8.18177 8.17924 8.50576 8.62488 8.5083 8.70837 
M1C 5.1817 4.94696 5.70844 6.20996 7.63702 7.67481 7.4338 8.30063 8.24072 8.76401 8.81716 8.54433 8.98324 
S1C 5.11409 5.0669 5.78491 6.08732 7.20511 7.34918 7.49815 8.22571 8.23977 8.5253 8.65136 8.62512 8.78295 
IPC 5.33142 5.14652 5.6251 5.78719 6.94682 7.13484 7.48906 8.09836 8.39355 8.4817 8.6171 8.36102 8.84213 
STC 5.50867 5.17567 5.49577 5.49605 6.90446 7.04308 7.5711 7.63023 8.01701 8.40091 8.60063 8.29088 8.67641 
A1C 5.4312 5.25355 5.0708 5.44266 6.88629 7.66737 7.45978 7.97217 8.08313 8.46055 8.62451 8.54243 8.87146 
ITC 5.33343 5.13264 6.07425 5.6178 6.70705 6.94853 7.43926 7.76186 8.02929 8.27266 8.28475 8.00919 8.318 
V1C 5.12673 5.20518 5.62942 5.73103 6.75611 7.25802 7.58477 7.9496 8.36782 8.30241 8.75848 8.81383 8.66904 
AMY 5.79869 5.83637 5.92513 6.33908 7.47543 7.53495 7.4593 7.6638 7.98269 8.1933 8.17634 8.52123 8.22639 
CBC 5.96013 6.00937 6.37943 6.59783 7.44187 6.9227 6.71348 7.22188 7.48566 7.94324 7.79456 7.4783 7.68466 
HIP 6.86782 6.33571 6.74357 7.172 7.80954 7.98804 7.81618 8.35939 8.04806 8.32982 8.67805 8.00056 8.54065 
MD 6.1307 5.80165 6.95031 7.49836 7.99381 8.13703 8.10044 8.63162 8.83625 8.64642 8.87579 8.72645 8.68057 
STR 6.15953 6.05918 6.30638 6.3601 7.95668 7.90099 7.87162 8.4529 8.47137 8.35768 8.62827 8.49047 8.21956 
 






























































Supplementary table 24: Data matrix representing log2 transformed values of CAPN1 (encoding for calpain 1 large subunit)in different regions at different 
developmental periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value 
of 5.5 was used to determine expression status). 
Area 3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 8.80621 8.75417 8.59564 8.95154 7.69589 8.01776 7.70949 6.95571 7.83768 8.02003 7.83309 7.68155 7.70423 
MFC 9.01074 8.88486 8.48467 8.804 7.50699 7.90592 7.94565 7.58587 7.96468 7.9242 7.80093 7.55859 7.83766 
DFC 8.77614 8.59005 8.48483 8.72512 7.9122 7.89185 7.59099 7.63043 7.99432 8.07869 7.95121 7.87265 8.04341 
VFC 8.64724 8.58252 8.52926 8.8192 7.77402 8.11075 7.72214 7.49025 8.10805 8.12695 8.04224 8.1463 7.57336 
M1C 8.71414 8.74351 8.53389 8.90929 7.48318 7.95419 7.75216 7.59279 8.21034 8.09039 8.23764 8.14722 8.29544 
S1C 8.66533 8.58202 8.56547 8.83185 7.43805 7.87517 7.71251 7.5439 8.39682 8.25172 8.07918 8.32753 7.88317 
IPC 8.36988 8.5535 8.42989 8.75362 7.38094 7.89599 7.80317 7.53127 7.75327 7.95375 8.205 7.99416 7.64178 
STC 8.10865 7.94741 8.22628 8.63607 7.91437 7.9296 7.52934 7.46528 7.7868 7.95933 7.98516 7.76984 7.87497 
A1C 8.22343 8.36543 8.41077 8.6226 7.82657 7.85988 7.42077 7.19078 7.94445 7.68519 8.04718 7.97627 7.68096 
ITC 7.65253 7.98808 8.53518 8.76376 7.90227 8.09737 7.80617 7.50279 7.85289 7.99137 7.91972 7.48203 7.53527 
V1C 8.58322 8.43703 8.17618 8.35573 7.36017 7.78378 7.77511 7.19879 8.30357 7.93261 7.96096 7.76742 7.60514 
AMY 7.86376 8.00903 7.98179 8.34954 7.44476 7.75334 7.99624 7.35258 7.97999 7.65987 7.57645 7.47327 7.45562 
CBC 8.70157 8.6051 8.35717 8.53546 8.18246 8.94806 8.4768 8.16932 8.36634 8.61008 8.37429 7.81741 8.11595 
HIP 8.29345 8.33742 8.55567 8.42582 7.39225 7.68421 7.7934 7.46272 8.24863 7.88058 7.58383 7.7757 7.51196 
MD 9.25852 9.50366 8.98476 8.74956 7.19519 8.55123 8.54955 8.29677 8.95265 8.26978 8.36489 8.25963 7.87508 
STR 8.39734 8.31041 8.44011 8.00823 6.90608 7.68348 7.79573 7.37503 8.94896 7.96224 7.49669 7.63587 7.70139 
 






























































Supplementary table 25: Data matrix representing log2 transformed values of CAPN2 (encoding for calpain 2 large subunit) in different regions at different 
developmental periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value 
of 5.5 was used to determine expression status). 
Area 3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 8.00893 7.81551 7.96956 7.7738 8.36856 8.35968 8.15064 8.62207 8.28394 8.54931 8.26754 8.45074 8.53703 
MFC 7.70277 7.76117 8.20161 7.70258 7.96788 8.4313 7.95538 8.70941 8.20249 8.67326 8.08316 8.43966 8.62286 
DFC 7.84812 7.77756 7.99442 7.72625 8.44829 8.19883 7.82782 8.58478 8.05211 8.19579 7.96073 8.20532 8.4695 
VFC 7.80161 7.38623 8.02249 7.91146 8.43477 7.74442 7.78382 8.87721 8.22978 8.39636 8.06885 8.29357 8.49054 
M1C 7.81856 7.54237 7.55543 7.76089 8.2564 8.4086 7.68544 8.62435 7.752 8.49494 8.29741 8.28711 8.6483 
S1C 7.7678 7.65783 7.45913 7.65716 8.15001 8.04877 7.48486 8.70903 8.04632 8.30641 8.25161 8.33664 8.35199 
IPC 7.3444 7.33608 7.86432 7.77446 8.1893 8.23136 7.2537 8.44247 8.23678 8.34442 8.17922 8.10365 8.65233 
STC 7.67973 7.3717 8.00019 7.87435 8.1686 8.40082 7.87274 8.06046 7.93811 8.43445 8.17312 7.95956 8.47598 
A1C 7.78331 7.5286 7.70349 7.92345 8.18934 8.40252 7.50422 8.39671 8.07569 8.48334 8.23 8.24688 8.436 
ITC 7.61002 7.24631 7.94798 8.0411 8.23728 8.24245 7.62679 8.30548 8.36707 8.44045 8.16145 8.07004 8.50576 
V1C 7.32983 7.04693 8.0046 8.01323 8.0006 8.33063 7.59679 8.3574 8.07605 8.18426 8.10675 8.33399 8.41474 
AMY 8.21763 8.16698 8.52108 8.3902 8.35441 8.63272 8.09952 8.34398 8.44574 8.60629 8.48872 8.92161 8.52166 
CBC 8.39097 8.20038 8.60079 8.62557 8.39233 9.17229 8.76864 8.88178 8.74019 8.93472 8.7921 8.79795 9.09173 
HIP 7.97106 7.88204 8.22633 8.13537 8.92875 8.6348 8.33919 8.75962 8.35529 8.72498 8.45313 8.3436 8.47304 
MD 8.06913 8.00027 8.45375 8.46299 8.41357 8.40303 8.56681 9.18447 9.07337 8.79034 8.98216 8.89861 8.88379 
STR 8.02983 7.96095 8.36494 8.26868 9.05501 8.7981 8.12492 8.72441 8.90522 8.69781 8.81528 8.85753 8.6807 
 






























































Supplementary table 26: Data matrix representing log2 transformed values of CAPNS1 (encoding for calpain small subunit 1) in different regions at different 
developmental periods. White cells represent samples where the gene is expressed, while gray cells represent samples considered not expressed (cutoff value 
of 5.5 was used to determine expression status). 
Area 3 4 5 6 7 8 9 10 11 12 13 14 15 
OFC 10.5594 10.6519 11.0793 11.2353 10.6546 11.3179 11.0659 10.183 10.8594 11.5992 11.3902 11.3771 11.3448 
MFC 10.7706 10.9277 11.2254 11.349 10.537 11.4274 11.1841 10.4953 11.0452 11.472 11.4885 11.2775 11.4959 
DFC 10.6492 10.882 11.2128 11.1189 10.5729 11.3501 11.0698 10.7686 11.0728 11.7666 11.5897 11.5638 11.6098 
VFC 10.717 10.7534 11.0164 11.185 10.5834 11.35 11.3622 10.6177 11.097 11.7347 11.5404 11.503 11.518 
M1C 10.7016 10.7087 10.7518 11.2576 10.4406 11.3463 11.4556 10.817 11.1318 11.6206 11.6053 11.6736 11.465 
S1C 10.6914 10.7679 10.6694 11.2122 10.2029 11.4667 11.0606 10.5871 11.1664 11.5379 11.4683 11.5738 11.3855 
IPC 10.7131 10.6575 11.0751 11.1223 10.4246 11.3217 11.3246 10.5548 10.8844 11.5904 11.6189 11.5397 11.4286 
STC 10.6445 10.8563 10.9843 11.0492 10.3688 11.3422 11.1245 10.67 10.9615 11.4042 11.5435 11.4841 11.3906 
A1C 10.802 10.8348 11.0602 11.0021 10.2361 11.3222 11.1179 10.6714 11.122 11.5226 11.4507 11.3825 11.4066 
ITC 10.4328 10.7944 10.765 10.9191 10.5258 11.3361 11.2519 10.4355 10.9869 11.5294 11.493 11.4147 11.3635 
V1C 10.7574 10.9724 10.9742 10.9436 9.71449 11.4264 10.8419 10.4859 10.9391 11.4011 11.3522 11.1855 11.0567 
AMY 10.7911 10.7774 10.6186 10.9827 10.4212 11.2261 11.2606 10.6464 11.0633 11.3745 11.3606 11.0643 11.0363 
CBC 10.7785 10.9209 11.2933 11.1614 10.963 11.5022 10.8033 10.5108 10.7466 11.6147 11.2214 10.9499 10.891 
HIP 11.0836 11.159 11.197 11.2249 10.3874 11.3292 11.1584 10.7445 11.0875 11.1167 11.4175 11.2465 11.349 
MD 10.8057 11.3699 11.0692 10.9616 10.4309 11.5383 11.277 11.1245 11.1742 11.5784 11.2764 10.9633 11.1584 
STR 10.468 10.5781 10.7203 10.5476 10.4905 11.0581 10.7307 10.874 11.4398 11.6296 11.1817 11.0766 11.2721 
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